{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T04:22:10Z","timestamp":1776572530288,"version":"3.51.2"},"reference-count":1042,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"DOI":"10.1093\/ejcts\/ezw313","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T22:08:42Z","timestamp":1474668522000},"page":"e1-e88","source":"Crossref","is-referenced-by-count":637,"title":["2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS"],"prefix":"10.1093","volume":"50","author":[{"given":"Paulus","family":"Kirchhof","sequence":"first","affiliation":[{"name":"* \u2002Corresponding authors: Paulus Kirchhof, Institute of Cardiovascular Sciences, University of Birmingham, SWBH and UHB NHS trusts, IBR, Room 136, Wolfson Drive, Birmingham B15 2TT, United Kingdom, Tel: +44 121 4147042, E-mail: p.kirchhof@bham.ac.uk; Stefano Benussi, Department of Cardiovascular Surgery, University Hospital Zurich, R\u00e4mistrasse 100, 8091 Z\u00fcrich, Switzerland, Tel: +41(0)788933835, E-mail: stefano.benussi@usz.ch."}]},{"given":"Stefano","family":"Benussi","sequence":"additional","affiliation":[{"name":"* \u2002Corresponding authors: Paulus Kirchhof, Institute of Cardiovascular Sciences, University of Birmingham, SWBH and UHB NHS trusts, IBR, Room 136, Wolfson Drive, Birmingham B15 2TT, United Kingdom, Tel: +44 121 4147042, E-mail: p.kirchhof@bham.ac.uk; Stefano Benussi, Department of Cardiovascular Surgery, University Hospital Zurich, R\u00e4mistrasse 100, 8091 Z\u00fcrich, Switzerland, Tel: +41(0)788933835, E-mail: stefano.benussi@usz.ch."}]},{"given":"Dipak","family":"Kotecha","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Ahlsson","sequence":"additional","affiliation":[]},{"given":"Dan","family":"Atar","sequence":"additional","affiliation":[]},{"given":"Barbara","family":"Casadei","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Castella","sequence":"additional","affiliation":[]},{"given":"Hans-Christoph","family":"Diener","sequence":"additional","affiliation":[]},{"given":"Hein","family":"Heidbuchel","sequence":"additional","affiliation":[]},{"given":"Jeroen","family":"Hendriks","sequence":"additional","affiliation":[]},{"given":"Gerhard","family":"Hindricks","sequence":"additional","affiliation":[]},{"given":"Antonis S.","family":"Manolis","sequence":"additional","affiliation":[]},{"given":"Jonas","family":"Oldgren","sequence":"additional","affiliation":[]},{"given":"Bogdan Alexandru","family":"Popescu","sequence":"additional","affiliation":[]},{"given":"Ulrich","family":"Schotten","sequence":"additional","affiliation":[]},{"given":"Bart","family":"Van Putte","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Vardas","sequence":"additional","affiliation":[]},{"given":"Stefan","family":"Agewall","sequence":"additional","affiliation":[]},{"given":"John","family":"Camm","sequence":"additional","affiliation":[]},{"given":"Gonzalo","family":"Baron Esquivias","sequence":"additional","affiliation":[]},{"given":"Werner","family":"Budts","sequence":"additional","affiliation":[]},{"given":"Scipione","family":"Carerj","sequence":"additional","affiliation":[]},{"given":"Filip","family":"Casselman","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Coca","sequence":"additional","affiliation":[]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[]},{"given":"Spiridon","family":"Deftereos","sequence":"additional","affiliation":[]},{"given":"Dobromir","family":"Dobrev","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 M.","family":"Ferro","sequence":"additional","affiliation":[]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[]},{"given":"Donna","family":"Fitzsimons","sequence":"additional","affiliation":[]},{"given":"Bulent","family":"Gorenek","sequence":"additional","affiliation":[]},{"given":"Maxine","family":"Guenoun","sequence":"additional","affiliation":[]},{"given":"Stefan H.","family":"Hohnloser","sequence":"additional","affiliation":[]},{"given":"Philippe","family":"Kolh","sequence":"additional","affiliation":[]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[]},{"given":"Athanasios","family":"Manolis","sequence":"additional","affiliation":[]},{"given":"John","family":"McMurray","sequence":"additional","affiliation":[]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[]},{"given":"Raphael","family":"Rosenhek","sequence":"additional","affiliation":[]},{"given":"Frank","family":"Ruschitzka","sequence":"additional","affiliation":[]},{"given":"Irina","family":"Savelieva","sequence":"additional","affiliation":[]},{"given":"Sanjay","family":"Sharma","sequence":"additional","affiliation":[]},{"given":"Piotr","family":"Suwalski","sequence":"additional","affiliation":[]},{"given":"Juan Luis","family":"Tamargo","sequence":"additional","affiliation":[]},{"given":"Clare J.","family":"Taylor","sequence":"additional","affiliation":[]},{"given":"Isabelle C.","family":"Van Gelder","sequence":"additional","affiliation":[]},{"given":"Adriaan A.","family":"Voors","sequence":"additional","affiliation":[]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[]},{"given":"Katja","family":"Zeppenfeld","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2016,9,23]]},"reference":[{"key":"2025110203564805100_ezw313C1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C5","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C6","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/CLEP.S47385","article-title":"Epidemiology of atrial fibrillation: European perspective","volume":"6","author":"Zoni-Berisso","year":"2014","journal-title":"Clin Epidemiol"},{"key":"2025110203564805100_ezw313C8","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/STROKEAHA.113.002329","article-title":"Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study","volume":"44","author":"Bjorck","year":"2013","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C9","doi-asserted-by":"crossref","first-page":"e001486","DOI":"10.1161\/JAHA.114.001486","article-title":"Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation","volume":"4","author":"Haim","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2025110203564805100_ezw313C10","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1161\/CIRCULATIONAHA.112.129759","article-title":"An update on the prognosis of patients with atrial fibrillation","volume":"126","author":"McManus","year":"2012","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C11","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","article-title":"Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century","volume":"167","author":"Ball","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C12","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C13","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.ijcard.2013.01.184","article-title":"Review of epidemiology and management of atrial fibrillation in developing countries","volume":"167","author":"Nguyen","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C14","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.113.005451","article-title":"Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry","volume":"129","author":"Oldgren","year":"2014","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCEP.112.970749","article-title":"Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry","volume":"5","author":"Chiang","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C16","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/STROKEAHA.113.003433","article-title":"Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"45","author":"Kishore","year":"2014","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C18","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C20","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"Stewart","year":"2002","journal-title":"Am J Med"},{"key":"2025110203564805100_ezw313C22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/ehs469","article-title":"All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study","volume":"34","author":"Andersson","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C23","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"key":"2025110203564805100_ezw313C26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1747-4949.2011.00706.x","article-title":"Comparison of cardiovascular risk factors and survival in patients with ischemic or hemorrhagic stroke","volume":"7","author":"Henriksson","year":"2012","journal-title":"Int J Stroke"},{"key":"2025110203564805100_ezw313C27","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1161\/STROKEAHA.113.001884","article-title":"Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study","volume":"44","author":"Grond","year":"2013","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.STR.28.2.316","article-title":"Atrial fibrillation and dementia in a population-based study","volume":"28","author":"Ott","year":"1997","journal-title":"The Rotterdam Study. Stroke"},{"key":"2025110203564805100_ezw313C29","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/eurheartj\/ehn341","article-title":"Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy","volume":"29","author":"Knecht","year":"2008","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/heartjnl-2012-303182","article-title":"Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management?","volume":"99","author":"Ball","year":"2013","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C31","doi-asserted-by":"crossref","first-page":"E329","DOI":"10.1503\/cmaj.111173","article-title":"Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies","volume":"184","author":"Marzona","year":"2012","journal-title":"CMAJ"},{"key":"2025110203564805100_ezw313C32","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.10.057","article-title":"Quality of life in patients with atrial fibrillation: a systematic review","volume":"119","author":"Thrall","year":"2006","journal-title":"Am J Med"},{"key":"2025110203564805100_ezw313C33","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/europace\/euv018","article-title":"Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: a longitudinal analysis\u2014data from the German Competence Network on Atrial Fibrillation","volume":"17","author":"von Eisenhart Rothe","year":"2015","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ahj.2014.02.003","article-title":"Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"167","author":"Steinberg","year":"2014","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/clc.22272","article-title":"Management of patients wtih atrial fibrillation by primary care physicians in Germany: 1-year results of the ATRIUM registry","volume":"37","author":"Kirchhof","year":"2014","journal-title":"Clin Cardiol"},{"key":"2025110203564805100_ezw313C36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/hrt.2002.008748","article-title":"Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK","volume":"90","author":"Stewart","year":"2004","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCOUTCOMES.110.958165","article-title":"Estimation of total incremental health care costs in patients with atrial fibrillation in the United States","volume":"4","author":"Kim","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025110203564805100_ezw313C38","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"2025110203564805100_ezw313C39","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C40","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2013.05.015","article-title":"Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial","volume":"166","author":"Kirchhof","year":"2013","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C41","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7326\/M13-1467","article-title":"Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review","volume":"160","author":"Al-Khatib","year":"2014","journal-title":"Ann Intern Med"},{"key":"2025110203564805100_ezw313C42","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1093\/eurheartj\/ehu374","article-title":"Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)","volume":"35","author":"Lip","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C43","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/CIRCULATIONAHA.112.000491","article-title":"Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study","volume":"128","author":"Marijon","year":"2013","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C44","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/STROKEAHA.115.009487","article-title":"Residual risk of stroke and death in anticoagulated patients according to the type of atrial fibrillation: AMADEUS Trial","volume":"46","author":"Senoo","year":"2015","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamainternmed.2013.11912","article-title":"Atrial fibrillation and the risk of myocardial infarction","volume":"174","author":"Soliman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025110203564805100_ezw313C46","doi-asserted-by":"crossref","first-page":"h7013","DOI":"10.1136\/bmj.h7013","article-title":"Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies","volume":"532","author":"Emdin","year":"2016","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrcardio.2016.45","article-title":"Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis","volume":"13","author":"Ko","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"2025110203564805100_ezw313C48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijcard.2014.09.092","article-title":"Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: A nationwide cohort study of 9519 patients","volume":"177","author":"Andersson","year":"2014","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C49","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.105.553438","article-title":"Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study","volume":"112","author":"Fang","year":"2005","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2013.10.035","article-title":"Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants","volume":"113","author":"Pancholy","year":"2014","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijcard.2011.04.022","article-title":"Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study","volume":"161","author":"Potpara","year":"2012","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C52","doi-asserted-by":"crossref","first-page":"e65795","DOI":"10.1371\/journal.pone.0065795","article-title":"Women versus men with chronic atrial fibrillation: insights from the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY)","volume":"8","author":"Ball","year":"2013","journal-title":"PLoS One"},{"key":"2025110203564805100_ezw313C53","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/qjmed\/hcm076","article-title":"Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review","volume":"100","author":"Hughes","year":"2007","journal-title":"QJM"},{"key":"2025110203564805100_ezw313C54","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1540-8159.2009.02335.x","article-title":"Gender differences in patients referred for atrial fibrillation management to a tertiary center","volume":"32","author":"Roten","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C55","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/europace\/eum144","article-title":"Gender-related differences in catheter ablation of atrial fibrillation","volume":"9","author":"Forleo","year":"2007","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C56","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/imi.0b013e3182a2306c","article-title":"Are there gender differences in outcomes after the Cox-Maze procedure for atrial fibrillation?","volume":"8","author":"Henry","year":"2013","journal-title":"Innovations (Phila)"},{"key":"2025110203564805100_ezw313C57","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.genm.2010.06.001","article-title":"Gender in atrial fibrillation: Ten years later","volume":"7","author":"Michelena","year":"2010","journal-title":"Gend Med"},{"key":"2025110203564805100_ezw313C58","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1001\/jama.291.23.2851","article-title":"Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C59","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jacc.2012.03.046","article-title":"Familial aggregation of lone atrial fibrillation in young persons","volume":"60","author":"Oyen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C60","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2261","article-title":"Meta-analysis identifies six new susceptibility loci for atrial fibrillation","volume":"44","author":"Ellinor","year":"2012","journal-title":"Nat Genet"},{"key":"2025110203564805100_ezw313C61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ejhg.2013.139","article-title":"Atrial fibrillation: the role of common and rare genetic variants","volume":"22","author":"Olesen","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"2025110203564805100_ezw313C62","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/CIRCULATIONAHA.114.009892","article-title":"Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation","volume":"130","author":"Sinner","year":"2014","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C63","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature06007","article-title":"Variants conferring risk of atrial fibrillation on chromosome 4q25","volume":"448","author":"Gudbjartsson","year":"2007","journal-title":"Nature"},{"key":"2025110203564805100_ezw313C64","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2013.12.015","article-title":"Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese","volume":"63","author":"Lubitz","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C65","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1161\/STROKEAHA.110.587980","article-title":"The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology","volume":"41","author":"Lemmens","year":"2010","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C66","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/STROKEAHA.114.006072","article-title":"Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke","volume":"45","author":"Tada","year":"2014","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C67","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.1073\/pnas.0912585107","article-title":"Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025110203564805100_ezw313C68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/cvr\/cvr078","article-title":"Modulation of conductive elements by Pitx2 and their impact on atrial arrhythmogenesis","volume":"91","author":"Franco","year":"2011","journal-title":"Cardiovasc Res"},{"key":"2025110203564805100_ezw313C69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/CIRCGENETICS.110.958058","article-title":"PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression","volume":"4","author":"Kirchhof","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"2025110203564805100_ezw313C70","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.1073\/pnas.1405411111","article-title":"Pitx2-microRNA pathway that delimits sinoatrial node development and inhibits predisposition to atrial fibrillation","volume":"111","author":"Wang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025110203564805100_ezw313C71","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2009.11.041","article-title":"Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation","volume":"55","author":"Husser","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C72","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.hrthm.2013.02.018","article-title":"Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion","volume":"10","author":"Parvez","year":"2013","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C73","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.hrthm.2012.11.012","article-title":"Common atrial fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial fibrillation ablation","volume":"10","author":"Benjamin Shoemaker","year":"2013","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C74","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2012.01.070","article-title":"Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation","volume":"60","author":"Parvez","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C75","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1093\/eurheartj\/ehu312","article-title":"The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology","volume":"35","author":"Kirchhof","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C76","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/europace\/eut232","article-title":"Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork\/European Heart Rhythm Association consensus conference","volume":"15","author":"Kirchhof","year":"2013","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C77","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C78","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cardiores.2005.04.016","article-title":"Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation","volume":"67","author":"Anne","year":"2005","journal-title":"Cardiovasc Res"},{"key":"2025110203564805100_ezw313C79","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biopha.2009.09.017","article-title":"Histological substrate of human atrial fibrillation","volume":"64","author":"Chimenti","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"2025110203564805100_ezw313C80","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.hrthm.2009.01.010","article-title":"Histopathological substrate for chronic atrial fibrillation in humans","volume":"6","author":"Nguyen","year":"2009","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C81","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","article-title":"Histological substrate of atrial biopsies in patients with lone atrial fibrillation","volume":"96","author":"Frustaci","year":"1997","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C82","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/eurheartj\/eht099","article-title":"Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines","volume":"36","author":"Venteclef","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C83","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/01.CIR.0000034511.06350.DF","article-title":"Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation","volume":"106","author":"Rocken","year":"2002","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C84","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/01.CIR.103.5.691","article-title":"Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation","volume":"103","author":"Schotten","year":"2001","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C85","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCEP.109.910125","article-title":"Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation","volume":"3","author":"Allessie","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C86","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1540-8167.1994.tb01157.x","article-title":"Initiating reentry: the role of nonuniform anisotropy in small circuits","volume":"5","author":"Spach","year":"1994","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C87","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/01.CIR.0000016826.62813.F5","article-title":"Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs","volume":"105","author":"Shinagawa","year":"2002","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C88","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jacc.2012.11.046","article-title":"Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm","volume":"61","author":"Lim","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C89","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/eurheartj\/eht024","article-title":"Biomarkers in atrial fibrillation: a clinical review","volume":"34","author":"Hijazi","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C90","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000109495.02213.52","article-title":"Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation","volume":"109","author":"Xu","year":"2004","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C91","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1540-8167.2007.00906.x","article-title":"Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation","volume":"18","author":"Gramley","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C92","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/cvr\/cvu045","article-title":"Epicardial adipose tissue and atrial fibrillation","volume":"102","author":"Hatem","year":"2014","journal-title":"Cardiovasc Res"},{"key":"2025110203564805100_ezw313C93","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ehj.2004.04.007","article-title":"Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation","volume":"25","author":"Leone","year":"2004","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C94","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1161\/CIRCULATIONAHA.105.575332","article-title":"The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation","volume":"112","author":"Dobrev","year":"2005","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C95","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.RES.85.5.428","article-title":"Atrial L-type Ca2+ currents and human atrial fibrillation","volume":"85","author":"Van Wagoner","year":"1999","journal-title":"Circ Res"},{"key":"2025110203564805100_ezw313C96","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1152\/physrev.00031.2009","article-title":"Pathophysiological mechanisms of atrial fibrillation: a translational appraisal","volume":"91","author":"Schotten","year":"2011","journal-title":"Physiol Rev"},{"key":"2025110203564805100_ezw313C97","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCULATIONAHA.113.006641","article-title":"Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation","volume":"129","author":"Voigt","year":"2014","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C98","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1161\/CIRCULATIONAHA.111.067306","article-title":"Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation","volume":"125","author":"Voigt","year":"2012","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C99","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0735-1097(01)01443-7","article-title":"Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria","volume":"38","author":"Polontchouk","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C100","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0735-1097(99)00382-4","article-title":"Myocardial cell death in fibrillating and dilated human right atria","volume":"34","author":"Aime-Sempe","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C101","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.hrthm.2004.06.010","article-title":"Cell size and communication: role in structural and electrical development and remodeling of the heart","volume":"1","author":"Spach","year":"2004","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C102","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.jacc.2008.01.055","article-title":"Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation","volume":"51","author":"Skalidis","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C103","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0167-5273(98)00228-9","article-title":"Atrial fibrillation in endomyocardial fibrosis is a marker of worse prognosis","volume":"67","author":"Barretto","year":"1998","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C104","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1111\/j.1540-8159.1997.tb06115.x","article-title":"Factors predisposing to the development of atrial fibrillation","volume":"20","author":"Levy","year":"1997","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C105","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/CIRCRESAHA.114.303772","article-title":"Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy","volume":"114","author":"Chen","year":"2014","journal-title":"Circ Res"},{"key":"2025110203564805100_ezw313C106","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.1073\/pnas.1324132111","article-title":"Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation","volume":"111","author":"Christ","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025110203564805100_ezw313C107","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1172\/JCI70102","article-title":"Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes","volume":"124","author":"Greiser","year":"2014","journal-title":"J Clin Invest"},{"key":"2025110203564805100_ezw313C108","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Haissaguerre","year":"1998","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C109","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1540-8167.2007.00909.x","article-title":"Spontaneous pulmonary vein firing in man: relationship to tachycardia-pause early afterdepolarizations and triggered arrhythmia in canine pulmonary veins in vitro","volume":"18","author":"Patterson","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C110","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/CIRCULATIONAHA.106.633735","article-title":"Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism","volume":"114","author":"Atienza","year":"2006","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C111","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/01.CIR.101.2.194","article-title":"Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart","volume":"101","author":"Mandapati","year":"2000","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C112","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1161\/01.CIR.0000147781.02738.13","article-title":"Epicardial mapping of chronic atrial fibrillation in patients: preliminary observations","volume":"110","author":"Sahadevan","year":"2004","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C113","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1540-8167.2006.00546.x","article-title":"Frequency mapping of the pulmonary veins in paroxysmal versus permanent atrial fibrillation","volume":"17","author":"Sanders","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C114","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-8703(59)90274-1","article-title":"Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge","volume":"58","author":"Moe","year":"1959","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0022-5223(19)36723-6","article-title":"The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation","volume":"101","author":"Cox","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C116","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jacc.2012.05.022","article-title":"Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial","volume":"60","author":"Narayan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C117","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/CIRCULATIONAHA.113.005421","article-title":"Driver domains in persistent atrial fibrillation","volume":"130","author":"Haissaguerre","year":"2014","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C118","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ehj.2004.04.015","article-title":"Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial","volume":"25","author":"Fetsch","year":"2004","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C119","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","article-title":"Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence","volume":"112","author":"Hindricks","year":"2005","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C120","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/eurheartj\/ehp235","article-title":"Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference \u2018research perspectives in AF\u2019","volume":"30","author":"Kirchhof","year":"2009","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C121","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijcard.2015.05.011","article-title":"Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age\/gender differences and cardiovascular outcomes","volume":"191","author":"Xiong","year":"2015","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C122","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1023\/A:1009823001707","article-title":"Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management","volume":"4","author":"Savelieva","year":"2000","journal-title":"J Interv Card Electrophysiol"},{"key":"2025110203564805100_ezw313C123","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehn599","article-title":"Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation","volume":"31","author":"Friberg","year":"2010","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C124","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/eurheartj\/ehu307","article-title":"Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES","volume":"36","author":"Vanassche","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial","volume":"36","author":"Steinberg","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C126","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bmj.39280.660567.55","article-title":"Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial","volume":"335","author":"Fitzmaurice","year":"2007","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C127","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/STROKEAHA.112.654954","article-title":"Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke","volume":"43","author":"Rizos","year":"2012","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C128","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/europace\/eus217","article-title":"Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)","volume":"15","author":"Friberg","year":"2013","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C130","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/europace\/eus087","article-title":"Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study","volume":"14","author":"Davis","year":"2012","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C131","doi-asserted-by":"crossref","DOI":"10.3310\/hta9400","article-title":"A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over","author":"Hobbs","year":"2005","journal-title":"The SAFE study. Health Technol Assess"},{"key":"2025110203564805100_ezw313C132","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/europace\/euv083","article-title":"Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording","volume":"17","author":"Aronsson","year":"2015","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C133","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/europace\/euu213","article-title":"A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke","volume":"17","author":"Levin","year":"2015","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C134","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH13-02-0165","article-title":"Screening to identify unknown atrial fibrillation","volume":"110","author":"Lowres","year":"2013","journal-title":"A systematic review. Thromb Haemost"},{"key":"2025110203564805100_ezw313C135","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/CIRCULATIONAHA.112.126656","article-title":"Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention","volume":"127","author":"Engdahl","year":"2013","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C136","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/europace\/eup262","article-title":"Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes","volume":"11","author":"Kaleschke","year":"2009","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C137","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/europace\/euu057","article-title":"Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation","volume":"16","author":"Tieleman","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C138","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2013.10.003","article-title":"Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring","volume":"127","author":"Barrett","year":"2014","journal-title":"Am J Med"},{"key":"2025110203564805100_ezw313C139","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1160\/TH14-03-0231","article-title":"Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies","volume":"111","author":"Lowres","year":"2014","journal-title":"The SEARCH-AF study. Thromb Haemost"},{"key":"2025110203564805100_ezw313C140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/HCO.0000000000000018","article-title":"Screening for undiagnosed atrial fibrillation in the community","volume":"29","author":"Quinn","year":"2014","journal-title":"Curr Opin Cardiol"},{"key":"2025110203564805100_ezw313C141","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C142","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCEP.109.877852","article-title":"Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation - results of the XPECT trial","volume":"3","author":"Hindricks","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C143","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C144","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jacc.2010.08.624","article-title":"Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators","volume":"57","author":"Santini","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C146","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.hrthm.2011.04.022","article-title":"Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS","volume":"8","author":"Daoud","year":"2011","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C147","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C148","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1056\/NEJMe1111948","article-title":"How much atrial fibrillation is too much atrial fibrillation?","volume":"366","author":"Lamas","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C149","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/europace\/eur241","article-title":"Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options\u2014a report from the 3rd Atrial Fibrillation Competence NETwork\/European Heart Rhythm Association consensus conference","volume":"14","author":"Kirchhof","year":"2012","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C150","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1160\/TH11-07-0517","article-title":"Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET\/EHRA consensus conference","volume":"106","author":"Kirchhof","year":"2011","journal-title":"Thromb Haemost"},{"key":"2025110203564805100_ezw313C151","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(15)70027-X","article-title":"Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis","volume":"14","author":"Sposato","year":"2015","journal-title":"Lancet Neurol"},{"key":"2025110203564805100_ezw313C152","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.0000000000002282","article-title":"Predictors for atrial fibrillation detection after cryptogenic stroke: Results from CRYSTAL AF","volume":"86","author":"Thijs","year":"2016","journal-title":"Neurology"},{"key":"2025110203564805100_ezw313C153","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C154","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"key":"2025110203564805100_ezw313C155","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/bmj.39227.551713.AE","article-title":"Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial","volume":"335","author":"Mant","year":"2007","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C156","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jacc.2003.08.027","article-title":"Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care","volume":"43","author":"Israel","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C157","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.114.014343","article-title":"Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study","volume":"131","author":"Svennberg","year":"2015","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C158","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/eurheartj\/ehv118","article-title":"Atrial flutter: more than just one of a kind","volume":"36","author":"Bun","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C159","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/S0735-1097(00)00982-7","article-title":"Incidence and predictors of atrial flutter in the general population","volume":"36","author":"Granada","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7326\/0003-4819-140-4-200402170-00008","article-title":"The natural history of lone atrial flutter","volume":"140","author":"Halligan","year":"2004","journal-title":"Ann Intern Med"},{"key":"2025110203564805100_ezw313C161","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/CIRCULATIONAHA.106.644484","article-title":"Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study","volume":"115","author":"Jahangir","year":"2007","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C162","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0002-9149(00)00792-X","article-title":"Temporal patterns of paroxysmal atrial fibrillation following DDDR pacemaker implantation","volume":"85","author":"Gillis","year":"2000","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C163","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jacc.2014.04.019","article-title":"Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices","volume":"63","author":"Charitos","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C164","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.ijcard.2012.06.118","article-title":"Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project","volume":"167","author":"Banerjee","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C165","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(12)61463-9","article-title":"Catheter ablation of atrial arrhythmias: state of the art","volume":"380","author":"Lee","year":"2012","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C166","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jacc.2014.01.023","article-title":"Lone atrial fibrillation: does it exist?","volume":"63","author":"Wyse","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C167","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ Res"},{"key":"2025110203564805100_ezw313C168","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.amjcard.2010.07.038","article-title":"Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose","volume":"106","author":"Chao","year":"2010","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C169","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1378\/chest.13-1740","article-title":"The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study","volume":"145","author":"Albertsen","year":"2014","journal-title":"Chest"},{"key":"2025110203564805100_ezw313C170","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/heartjnl-2013-304036","article-title":"Alcohol intake and prognosis of atrial fibrillation","volume":"99","author":"Overvad","year":"2013","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C171","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jacc.2010.09.049","article-title":"Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation","volume":"57","author":"Daccarett","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C172","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jacc.2013.07.067","article-title":"The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation","volume":"62","author":"Neilan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C173","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.2014.3","article-title":"Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study","volume":"311","author":"Marrouche","year":"2014","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C174","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/europace\/euu202","article-title":"Systematic comparison of non-invasive measures for the assessment of atrial fibrillation complexity: a step forward towards standardization of atrial fibrillation electrogram analysis","volume":"17","author":"Bonizzi","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/europace\/euv304","article-title":"A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network\/European Heart Rhythm Association consensus conference","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C176","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.194","article-title":"Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment","volume":"13","author":"Fabritz","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"2025110203564805100_ezw313C177","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0735-1097(00)00886-X","article-title":"The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy","volume":"36","author":"Dorian","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C178","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1540-8159.2005.00171.x","article-title":"Understanding atrial symptom reports: objective versus subjective predictors","volume":"28","author":"Sears","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C179","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0300-8932(10)70266-9","article-title":"Variation in quality of life with type of atrial fibrillation","volume":"63","author":"Peinado","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"2025110203564805100_ezw313C180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/heartjnl-2011-300550","article-title":"Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry","volume":"98","author":"Steg","year":"2012","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C181","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0195-668X(03)00261-6","article-title":"Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study","volume":"24","author":"Gronefeld","year":"2003","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CMC.S10628","article-title":"Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials","volume":"7","author":"Pepine","year":"2013","journal-title":"Clin Med Insights Cardiol"},{"key":"2025110203564805100_ezw313C183","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jacc.2003.08.037","article-title":"Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study","volume":"43","author":"Hagens","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C184","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0735-1097(03)00338-3","article-title":"The Australian intervention randomized control of rate in atrial fibrillation trial (AIRCRAFT)","volume":"41","author":"Weerasooriya","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C185","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","article-title":"A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure","volume":"61","author":"Jones","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C186","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1161\/CIRCULATIONAHA.111.069450","article-title":"Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities","volume":"125","author":"Rienstra","year":"2012","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C187","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/europace\/eup421","article-title":"Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation","volume":"12","author":"Arribas","year":"2010","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C188","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCEP.110.958033","article-title":"Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation","volume":"4","author":"Spertus","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C189","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ahj.2013.04.015","article-title":"Interpreting changes in quality of life in atrial fibrillation: How much change is meaningful?","volume":"166","author":"Dorian","year":"2013","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C190","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0895-4356(98)00081-X","article-title":"Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project","volume":"51","author":"Ware","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2025110203564805100_ezw313C191","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"2025110203564805100_ezw313C192","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/eurheartj\/ehm358","article-title":"Outcome parameters for trials in atrial fibrillation: executive summary","volume":"28","author":"Kirchhof","year":"2007","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C193","first-page":"383","article-title":"A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale","volume":"22","author":"Dorian","year":"2006","journal-title":"Can J Cardiol"},{"key":"2025110203564805100_ezw313C194","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/eut263","article-title":"Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events\u2014European Registry in Atrial Fibrillation (PREFER in AF)","volume":"16","author":"Kirchhof","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C195","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/europace\/euv269","article-title":"Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry","volume":"17","author":"Lip","year":"2015","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C196","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/CIRCOUTCOMES.114.001303","article-title":"Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"8","author":"Freeman","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025110203564805100_ezw313C197","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.amjmed.2014.11.026","article-title":"Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry","volume":"128","author":"Boriani","year":"2015","journal-title":"Am J Med"},{"key":"2025110203564805100_ezw313C198","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/AC.69.3.3027832","article-title":"Occurrence of poor sleep quality in atrial fibrillation patients according to the EHRA score","volume":"69","author":"Szymanski","year":"2014","journal-title":"Acta Cardiol"},{"key":"2025110203564805100_ezw313C199","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/europace\/eut395","article-title":"The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification","volume":"16","author":"Wynn","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C200","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00392-011-0320-5","article-title":"Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry","volume":"100","author":"Meinertz","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"2025110203564805100_ezw313C201","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/europace\/eun369","article-title":"The Registry of the German Competence NETwork on Atrial Fibrillation: Patient characteristics and initial management","volume":"11","author":"Nabauer","year":"2009","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C202","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/europace\/eut361","article-title":"Depression in paroxysmal and persistent atrial fibrillation patients: a cross-sectional comparison of patients enroled in two large clinical trials","volume":"16","author":"von Eisenhart Rothe","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C203","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C204","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C205","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1161\/01.CIR.96.7.2455","article-title":"Incidence of and risk factors for atrial fibrillation in older adults","volume":"96","author":"Psaty","year":"1997","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C206","doi-asserted-by":"crossref","first-page":"e7895","DOI":"10.1136\/bmj.e7895","article-title":"The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study","volume":"345","author":"Selmer","year":"2012","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C207","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2013.10.012","article-title":"Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study)","volume":"167","author":"Kim","year":"2014","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C208","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jacc.2015.06.1314","article-title":"Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: A community-based study from the netherlands","volume":"66","author":"Vermond","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C209","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1183\/09031936.03.00051502","article-title":"Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study","volume":"21","author":"Buch","year":"2003","journal-title":"Eur Respir J"},{"key":"2025110203564805100_ezw313C210","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacc.2006.08.060","article-title":"Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C211","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCEP.110.957100","article-title":"Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study","volume":"4","author":"Baber","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C212","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.hrthm.2011.03.038","article-title":"Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study","volume":"8","author":"Chamberlain","year":"2011","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C213","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2014.03.048","article-title":"Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis","volume":"64","author":"Larsson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C214","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.amjcard.2009.01.374","article-title":"Relation of vigorous exercise to risk of atrial fibrillation","volume":"103","author":"Aizer","year":"2009","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1573403X11309020005","article-title":"Heart failure epidemiology: European perspective","volume":"9","author":"Guha","year":"2013","journal-title":"Curr Cardiol Rev"},{"key":"2025110203564805100_ezw313C216","doi-asserted-by":"crossref","first-page":"ii13","DOI":"10.1093\/europace\/eur081","article-title":"What are the costs of heart failure?","volume":"13","author":"Braunschweig","year":"2011","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C217","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jval.2011.09.009","article-title":"A review of the cost of atrial fibrillation","volume":"15","author":"Wodchis","year":"2012","journal-title":"Value Health"},{"key":"2025110203564805100_ezw313C218","first-page":"3250","article-title":"Atrial fibrillation in heart failure: what should we do?","volume":"36","author":"Kotecha","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C219","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"47","author":"Olsson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C220","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","article-title":"Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes","volume":"203","author":"Kotecha","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C221","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurjhf\/hfp085","article-title":"A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure","volume":"11","author":"Mamas","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2025110203564805100_ezw313C222","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","author":"Ponikowski","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C223","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/europace\/euv191","article-title":"European Heart Rhythm Association\/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society","volume":"18","author":"Lip","year":"2016","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C224","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C225","doi-asserted-by":"crossref","first-page":"h4451","DOI":"10.1136\/bmj.h4451","article-title":"Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data","volume":"351","author":"Ziff","year":"2015","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C226","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/CIRCEP.114.001938","article-title":"Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis","volume":"7","author":"Anselmino","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C227","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.hlc.2014.09.012","article-title":"Catheter ablation of atrial fibrillation in patients with concomitant left ventricular impairment: a systematic review of efficacy and effect on ejection fraction","volume":"24","author":"Ganesan","year":"2015","journal-title":"Heart Lung Circ"},{"key":"2025110203564805100_ezw313C228","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa0708234","article-title":"Pulmonary-vein isolation for atrial fibrillation in patients with heart failure","volume":"359","author":"Khan","year":"2008","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C229","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2013.12.180","article-title":"Tachycardia mediated cardiomyopathy: pathophysiology, mechanisms, clinical features and management","volume":"172","author":"Gupta","year":"2014","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C230","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jcmg.2009.05.013","article-title":"Clinical utility of single-beat E\/e' obtained by simultaneous recording of flow and tissue Doppler velocities in atrial fibrillation with preserved systolic function","volume":"2","author":"Kusunose","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025110203564805100_ezw313C231","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/ejechocard\/jep218","article-title":"Will simultaneous measurement of E\/e' index facilitate the non-invasive assessment of left ventricular filling pressure in patients with non-valvular atrial fibrillation?","volume":"11","author":"Li","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"2025110203564805100_ezw313C232","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1540-8175.2007.00555.x","article-title":"A simple Doppler echocardiography method to evaluate pulmonary capillary wedge pressure in patients with atrial fibrillation","volume":"25","author":"Senechal","year":"2008","journal-title":"Echocardiography"},{"key":"2025110203564805100_ezw313C233","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0894-7317(99)70145-8","article-title":"Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation","volume":"12","author":"Sohn","year":"1999","journal-title":"J Am Soc Echocardiogr"},{"key":"2025110203564805100_ezw313C234","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1253\/circj.CJ-11-0703","article-title":"Simultaneous Doppler tracing of transmitral inflow and mitral annular velocity as an estimate of elevated left ventricular filling pressure in patients with atrial fibrillation","volume":"76","author":"Wada","year":"2012","journal-title":"Circ J"},{"key":"2025110203564805100_ezw313C235","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jacc.2015.03.043","article-title":"Patient selection in heart failure with preserved ejection fraction clinical trials","volume":"65","author":"Kelly","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C236","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis","volume":"55","author":"Schneider","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C237","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis","volume":"45","author":"Healey","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C238","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MJT.0b013e31804beb59","article-title":"Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis","volume":"15","author":"Jibrini","year":"2008","journal-title":"Am J Ther"},{"key":"2025110203564805100_ezw313C239","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2005.06.036","article-title":"Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"152","author":"Ducharme","year":"2006","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C240","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa0805710","article-title":"Valsartan for prevention of recurrent atrial fibrillation","volume":"360","author":"GISSI-AF Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C241","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.111.965178","article-title":"Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial","volume":"5","author":"Goette","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C242","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1008816","article-title":"Irbesartan in patients with atrial fibrillation","volume":"364","author":"Active I Investigators","year":"2011","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C243","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C244","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0735-1097(00)00611-2","article-title":"Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation","volume":"35","author":"Goette","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C245","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/eurheartj\/eht507","article-title":"Antihypertensive treatment and risk of atrial fibrillation: a nationwide study","volume":"35","author":"Marott","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C246","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C247","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/HJH.0b013e32834f03bf","article-title":"Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group \u2018Hypertension Arrhythmias and Thrombosis\u2019 of the European Society of Hypertension","volume":"30","author":"Manolis","year":"2012","journal-title":"J Hypertens"},{"key":"2025110203564805100_ezw313C248","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/01.CIR.0000022665.18619.83","article-title":"Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study","volume":"106","author":"Madrid","year":"2002","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C249","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.ehj.2003.08.014","article-title":"Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study","volume":"24","author":"Ueng","year":"2003","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C250","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ahj.2006.01.007","article-title":"Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation","volume":"152","author":"Anand","year":"2006","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C251","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.amjcard.2007.01.030","article-title":"Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation","volume":"99","author":"Tveit","year":"2007","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C252","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9149(94)90363-8","article-title":"Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)","volume":"74","author":"Furberg","year":"1994","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C253","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C254","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C255","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C256","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.amjcard.2014.09.007","article-title":"Prognostic significance of atrial fibrillation and severity of symptoms of heart failure in patients with low gradient aortic stenosis and preserved left ventricular ejection fraction","volume":"114","author":"Moretti","year":"2014","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C257","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.athoracsur.2007.04.036","article-title":"Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified?","volume":"84","author":"Ngaage","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C258","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.athoracsur.2006.04.004","article-title":"Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery?","volume":"82","author":"Ngaage","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C259","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/eurheartj\/ehi272","article-title":"Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation","volume":"26","author":"Eguchi","year":"2005","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C260","doi-asserted-by":"crossref","first-page":"I59","DOI":"10.1161\/hc37t1.094813","article-title":"Influence of atrial fibrillation on outcome following mitral valve repair","volume":"104","author":"Lim","year":"2001","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C261","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.amjcard.2014.10.027","article-title":"Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement","volume":"115","author":"Maan","year":"2015","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C262","first-page":"468","article-title":"Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation","volume":"85","author":"Barbash","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025110203564805100_ezw313C263","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/01.STR.19.8.937","article-title":"Atrial fibrillation and stroke: new ideas, persisting dilemmas","volume":"19","author":"Halperin","year":"1988","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C264","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/eurheartj\/ehm199","article-title":"Left atrial remodelling in mitral regurgitation\u2014methodologic approach, physiological determinants, and outcome implications: a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study","volume":"28","author":"Messika-Zeitoun","year":"2007","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C265","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1016\/j.ijcard.2013.07.017","article-title":"Impact of atrial fibrillation-induced tachycardiomyopathy in patients undergoing pulmonary vein isolation","volume":"168","author":"Calvo","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C266","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/hrt.74.3.261","article-title":"Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation","volume":"74","author":"Edner","year":"1995","journal-title":"Br Heart J"},{"key":"2025110203564805100_ezw313C267","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jacc.2011.06.032","article-title":"Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control","volume":"58","author":"Gertz","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C268","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1540-8175.2009.00904.x","article-title":"Mitral regurgitation associated with mitral annular dilation in patients with lone atrial fibrillation: an echocardiographic study","volume":"26","author":"Kihara","year":"2009","journal-title":"Echocardiography"},{"key":"2025110203564805100_ezw313C269","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1253\/circj.66.913","article-title":"Impact of atrial fibrillation on tricuspid and mitral annular dilatation and valvular regurgitation","volume":"66","author":"Zhou","year":"2002","journal-title":"Circ J"},{"key":"2025110203564805100_ezw313C270","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ehjci\/jet191","article-title":"Mechanisms of atrial mitral regurgitation: insights using 3D transoesophageal echo","volume":"15","author":"Ring","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025110203564805100_ezw313C271","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejcts\/ezs455","article-title":"Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Vahanian","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C272","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/europace\/euu178","article-title":"The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey","volume":"16","author":"Molteni","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C273","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C274","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/bmj.1.5392.1209","article-title":"Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease","volume":"1","author":"Szekely","year":"1964","journal-title":"Br Med J"},{"key":"2025110203564805100_ezw313C275","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1093\/eurheartj\/ehu352","article-title":"What is \u2018valvular\u2019 atrial fibrillation? A reappraisal","volume":"35","author":"De Caterina","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C276","first-page":"220","article-title":"Early surgical intervention or watchful waiting for the management of asymptomatic mitral regurgitation: a systematic review and meta-analysis","volume":"4","author":"Goldstone","year":"2015","journal-title":"Ann Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C277","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jacc.2012.06.030","article-title":"Type 2 diabetes mellitus and risk of incident atrial fibrillation in women","volume":"60","author":"Schoen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C278","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/eurheartj\/ehp055","article-title":"Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study","volume":"30","author":"Du","year":"2009","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C279","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdiacomp.2014.09.002","article-title":"Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes","volume":"29","author":"Rizzo","year":"2015","journal-title":"J Diabetes Complications"},{"key":"2025110203564805100_ezw313C280","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00424-009-0771-y","article-title":"Human K(ATP) channelopathies: diseases of metabolic homeostasis","volume":"460","author":"Olson","year":"2010","journal-title":"Pflugers Arch"},{"key":"2025110203564805100_ezw313C281","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C282","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2025110203564805100_ezw313C283","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jce.12560","article-title":"Defining the role of oxidative stress in atrial fibrillation and diabetes","volume":"26","author":"Ziolo","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C284","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.amjcard.2014.07.045","article-title":"Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)","volume":"114","author":"Fatemi","year":"2014","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C285","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/STROKEAHA.115.009371","article-title":"Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study","volume":"46","author":"Overvad","year":"2015","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C286","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-014-0123-x","article-title":"Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies","volume":"13","author":"Chang","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"2025110203564805100_ezw313C287","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1378\/chest.14-2096","article-title":"The impact of associated diabetic retinopathy on stroke and severe bleeding risk in diabetic patients with atrial fibrillation: the Loire valley atrial fibrillation project","volume":"147","author":"Lip","year":"2015","journal-title":"Chest"},{"key":"2025110203564805100_ezw313C288","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCEP.113.001244","article-title":"Physical activity, obesity, weight change, and risk of atrial fibrillation: the Atherosclerosis Risk in Communities study","volume":"7","author":"Huxley","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C289","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/eurheartj\/ehi506","article-title":"Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study)","volume":"27","author":"Murphy","year":"2006","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C290","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ahj.2007.10.004","article-title":"Atrial fibrillation and obesity\u2014results of a meta-analysis","volume":"155","author":"Wanahita","year":"2008","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C291","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C292","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.amjmed.2012.11.024","article-title":"Body mass index and adverse events in patients with incident atrial fibrillation","volume":"126","author":"Overvad","year":"2013","journal-title":"Am J Med"},{"key":"2025110203564805100_ezw313C293","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0002-9149(99)00066-1","article-title":"Heart rate variability in obesity and the effect of weight loss","volume":"83","author":"Karason","year":"1999","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C294","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jacc.2010.10.042","article-title":"Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort","volume":"57","author":"Russo","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C295","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults","volume":"282","author":"Visser","year":"1999","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C296","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C297","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study","volume":"66","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C298","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1161\/CIRCULATIONAHA.107.716712","article-title":"Catheter ablation for atrial fibrillation in patients with obesity","volume":"117","author":"Cha","year":"2008","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C299","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1540-8167.2008.01118.x","article-title":"Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation","volume":"19","author":"Jongnarangsin","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C300","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/pace.12106","article-title":"Impact of body mass index on atrial fibrillation recurrence: a meta-analysis of observational studies","volume":"36","author":"Guijian","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C301","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/clc.22108","article-title":"Influence of body mass index on recurrence and quality of life in atrial fibrillation patients after catheter ablation: a meta-analysis and systematic review","volume":"36","author":"Zhuang","year":"2013","journal-title":"Clin Cardiol"},{"key":"2025110203564805100_ezw313C302","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jacc.2007.03.040","article-title":"Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation","volume":"50","author":"Ector","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C303","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.amjcard.2012.10.013","article-title":"Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation","volume":"111","author":"Shoemaker","year":"2013","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C304","article-title":"Obstructive sleep apnoea-hypopnoea and arrhythmias: new updates","author":"Vizzardi","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2025110203564805100_ezw313C305","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/157340312803760811","article-title":"Sleep apnea and atrial fibrillation; 2012 update","volume":"8","author":"Digby","year":"2012","journal-title":"Curr Cardiol Rev"},{"key":"2025110203564805100_ezw313C306","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1042\/CS20110178","article-title":"Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium","volume":"122","author":"Lin","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"2025110203564805100_ezw313C307","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.amjcard.2012.07.001","article-title":"Atrial fibrillation in obstructive sleep apnea: atrial arrhythmogenic substrate of a different sort","volume":"110","author":"Linz","year":"2012","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C308","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/CIRCEP.109.858381","article-title":"Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure","volume":"3","author":"Patel","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C309","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2013.03.052","article-title":"Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation","volume":"62","author":"Fein","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C310","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.hrthm.2012.11.015","article-title":"Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy","volume":"10","author":"Naruse","year":"2013","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C311","doi-asserted-by":"crossref","first-page":"e000421","DOI":"10.1161\/JAHA.113.000421","article-title":"Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation","volume":"2","author":"Neilan","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2025110203564805100_ezw313C312","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/europace\/euu066","article-title":"Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies","volume":"16","author":"Li","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C313","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa1506459","article-title":"Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure","volume":"373","author":"Cowie","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C314","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1540-8167.2011.02148.x","article-title":"Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: the independent role of sleep-disordered breathing","volume":"23","author":"Bitter","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2011.02.343","article-title":"Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation","volume":"108","author":"Ng","year":"2011","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C316","first-page":"S71","article-title":"Stroke prevention in atrial fibrillation patients with chronic kidney disease","volume":"29","author":"Hart","year":"2013","journal-title":"Can J Cardiol"},{"key":"2025110203564805100_ezw313C317","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.amjcard.2012.12.045","article-title":"Renal impairment in a \"real-life\" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding)","volume":"111","author":"Roldan","year":"2013","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C318","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C319","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C320","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C321","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C322","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5694\/mja14.00032","article-title":"A systematic approach to chronic heart failure care: a consensus statement","volume":"201","author":"Page","year":"2014","journal-title":"Med J Aust"},{"key":"2025110203564805100_ezw313C323","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1377\/hlthaff.2014.0428","article-title":"Chronic care model strategies in the United States and Germany deliver patient-centered, high-quality diabetes care","volume":"33","author":"Stock","year":"2014","journal-title":"Health Aff (Millwood)"},{"key":"2025110203564805100_ezw313C324","first-page":"1119","article-title":"The effectiveness of structured personal care of type 2 diabetes on recurrent outcomes: a 19 year follow-up of the study Diabetes Care in General Practice (DCGP)","volume":"57","author":"Lundstrom","year":"2014","journal-title":"Diabetologia"},{"key":"2025110203564805100_ezw313C325","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/eht096","article-title":"A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice","volume":"34","author":"Berti","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C326","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2307\/3350391","article-title":"Organizing care for patients with chronic illness","volume":"74","author":"Wagner","year":"1996","journal-title":"Milbank Q"},{"key":"2025110203564805100_ezw313C327","first-page":"1006","article-title":"Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation","volume":"153","author":"Nieuwlaat","year":"2007","journal-title":"The Euro Heart Survey on Atrial Fibrillation. Am Heart J"},{"key":"2025110203564805100_ezw313C328","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.healthpol.2011.10.006","article-title":"Integrated care for chronic conditions: the contribution of the ICCC Framework","volume":"105","author":"Nuno","year":"2012","journal-title":"Health Policy"},{"key":"2025110203564805100_ezw313C329","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1160\/TH11-02-0070","article-title":"Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions","volume":"105","author":"Kirchhof","year":"2011","journal-title":"Thromb Haemost"},{"key":"2025110203564805100_ezw313C330","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1093\/eurheartj\/ehs071","article-title":"Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation","volume":"33","author":"Hendriks","year":"2012","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C331","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/europace\/eut055","article-title":"Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation","volume":"15","author":"Hendriks","year":"2013","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C332","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0140-6736(14)61992-9","article-title":"Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial","volume":"385","author":"Stewart","year":"2015","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C333","first-page":"55","article-title":"A multidisciplinary atrial fibrillation clinic","volume":"9","author":"Tran","year":"2013","journal-title":"Curr Cardiol Rev"},{"key":"2025110203564805100_ezw313C334","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.ajem.2012.04.022","article-title":"Clinical management of atrial fibrillation: early interventions, observation, and structured follow-up reduce hospitalizations","volume":"30","author":"Conti","year":"2012","journal-title":"Am J Emerg Med"},{"key":"2025110203564805100_ezw313C335","doi-asserted-by":"crossref","first-page":"e002950","DOI":"10.1161\/JAHA.115.002950","article-title":"An Integrated Management Approach to Atrial Fibrillation","volume":"5","author":"Carter","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2025110203564805100_ezw313C336","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/CIR.0000000000000139","article-title":"ACC\/AHA\/AACVPR\/AAFP\/ANA Concepts for Clinician-Patient Shared Accountability in Performance Measures: A Report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"130","author":"Peterson","year":"2014","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C337","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/europace\/euv233","article-title":"Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)","volume":"17","author":"Lane","year":"2015","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C338","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ijnurstu.2009.12.017","article-title":"An integrated chronic care program for patients with atrial fibrillation: study protocol and methodology for an ongoing prospective randomised controlled trial","volume":"47","author":"Hendriks","year":"2010","journal-title":"Int J Nurs Stud"},{"key":"2025110203564805100_ezw313C339","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ehjci\/jev354","article-title":"EACVI\/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation","volume":"17","author":"Donal","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025110203564805100_ezw313C340","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the European association of cardiovascular imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025110203564805100_ezw313C341","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ahj.2014.10.005","article-title":"High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study","volume":"169","author":"Filion","year":"2015","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C342","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C343","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.873265","article-title":"N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study","volume":"120","author":"Patton","year":"2009","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C344","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1053\/euhj.2001.2943","article-title":"Transoesophageal echocardiography for immediate and safe cardioversion in patients with atrial fibrillation","volume":"22","author":"Bartel","year":"2001","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C345","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00399-014-0327-5","article-title":"[Relevance of magnetic resonance imaging for catheter ablation of atrial fibrillation]","volume":"25","author":"Mahnkopf","year":"2014","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"2025110203564805100_ezw313C346","doi-asserted-by":"crossref","first-page":"658937","DOI":"10.1155\/2012\/658937","article-title":"The use of cardiac magnetic resonance imaging in the diagnostic workup and treatment of atrial fibrillation","volume":"2012","author":"Haemers","year":"2012","journal-title":"Cardiol Res Pract"},{"key":"2025110203564805100_ezw313C347","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/j.jacc.2012.07.065","article-title":"Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction","volume":"60","author":"Ling","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C348","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/europace\/eut043","article-title":"An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation","volume":"15","author":"Lewalter","year":"2013","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C349","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/eurheartj\/ehm358","article-title":"Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA)","volume":"28","author":"Kirchhof","year":"2007","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C350","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1472-6963-8-221","article-title":"Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study","volume":"8","author":"Alonso-Coello","year":"2008","journal-title":"BMC Health Serv Res"},{"key":"2025110203564805100_ezw313C351","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001179","article-title":"Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches?","volume":"3","author":"Lip","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2025110203564805100_ezw313C352","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/jth.12845","article-title":"Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study","volume":"13","author":"Gorst-Rasmussen","year":"2015","journal-title":"J Thromb Haemost"},{"key":"2025110203564805100_ezw313C353","doi-asserted-by":"crossref","first-page":"590","DOI":"10.7326\/0003-4819-147-8-200710160-00018","article-title":"Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation","volume":"147","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"2025110203564805100_ezw313C354","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C355","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/j.hrthm.2015.04.039","article-title":"HRS\/NSA 2014 Survey of Atrial Fibrillation and Stroke: Gaps in Knowledge and Perspective, Opportunities for Improvement","volume":"12","author":"Frankel","year":"2015","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C356","first-page":"833","article-title":"Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry","volume":"111","author":"Le Heuzey","year":"2014","journal-title":"Thromb Haemost"},{"key":"2025110203564805100_ezw313C357","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ahj.2013.12.014","article-title":"Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry","volume":"167","author":"O'Brien","year":"2014","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C358","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCOUTCOMES.110.937680","article-title":"Warfarin discontinuation after starting warfarin for atrial fibrillation","volume":"3","author":"Fang","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025110203564805100_ezw313C359","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/CIRCOUTCOMES.113.000192","article-title":"Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin","volume":"6","author":"Zalesak","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025110203564805100_ezw313C360","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.amjmed.2012.01.033","article-title":"Risk of falls and major bleeds in patients on oral anticoagulation therapy","volume":"125","author":"Donze","year":"2012","journal-title":"Am J Med"},{"key":"2025110203564805100_ezw313C361","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archinte.159.7.677","article-title":"Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls","volume":"159","author":"Man-Son-Hing","year":"1999","journal-title":"Arch Intern Med"},{"key":"2025110203564805100_ezw313C362","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C363","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1474-4422(12)70017-0","article-title":"Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial","volume":"11","author":"Diener","year":"2012","journal-title":"Lancet Neurol"},{"key":"2025110203564805100_ezw313C364","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jama.279.16.1273","article-title":"Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study","volume":"279","author":"The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators","year":"1998","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C365","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C366","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archinte.163.8.936","article-title":"A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin","volume":"163","author":"van Walraven","year":"2003","journal-title":"Arch Intern Med"},{"key":"2025110203564805100_ezw313C367","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.290.8.1049","article-title":"A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study","volume":"290","author":"Wang","year":"2003","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C368","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"2025110203564805100_ezw313C369","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C370","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/eurheartj\/ehs446","article-title":"Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology\/European Heart Rhythm Association\/European Association of Cardiothoracic Surgeons, the American College of Cardiology Foundation\/American Heart Association\/Heart Rhythm Society, and the Canadian Cardiovascular Society","volume":"34","author":"Kirchhof","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C371","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C372","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2014.11.046","article-title":"Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?","volume":"65","author":"Chao","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C373","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jacc.2015.01.044","article-title":"Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score","volume":"65","author":"Lip","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C374","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1378\/chest.15-1622","article-title":"Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project","volume":"149","author":"Fauchier","year":"2016","journal-title":"Chest"},{"key":"2025110203564805100_ezw313C375","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/STROKEAHA.115.012609","article-title":"Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis","volume":"47","author":"Joundi","year":"2016","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C376","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacc.2014.10.052","article-title":"Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1","volume":"65","author":"Friberg","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C377","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1160\/TH15-07-0565","article-title":"Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy","volume":"114","author":"Lip","year":"2015","journal-title":"Thromb Haemost"},{"key":"2025110203564805100_ezw313C378","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/j.1538-7836.2012.04853.x","article-title":"Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study","volume":"10","author":"Mikkelsen","year":"2012","journal-title":"J Thromb Haemost"},{"key":"2025110203564805100_ezw313C379","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/qjmed\/hcu054","article-title":"Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis","volume":"107","author":"Wagstaff","year":"2014","journal-title":"QJM"},{"key":"2025110203564805100_ezw313C380","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","article-title":"Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy","volume":"125","author":"Hijazi","year":"2012","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C381","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.jacc.2012.11.082","article-title":"N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation)","volume":"61","author":"Hijazi","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C382","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C383","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C384","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"2025110203564805100_ezw313C385","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C386","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C387","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C388","first-page":"3258","article-title":"The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation","volume":"36","author":"O'Brien","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C389","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00277-011-1267-3","article-title":"Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules","volume":"90","author":"Loewen","year":"2011","journal-title":"Ann Hematol"},{"key":"2025110203564805100_ezw313C390","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1538-7836.2011.04378.x","article-title":"Bleeding risk in \u2018real world\u2019 patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort","volume":"9","author":"Olesen","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2025110203564805100_ezw313C391","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1538-7836.2010.04085.x","article-title":"A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice","volume":"9","author":"Van Staa","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2025110203564805100_ezw313C392","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2013.08.1623","article-title":"The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation","volume":"62","author":"Roldan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C393","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1161\/CIRCULATIONAHA.114.011204","article-title":"Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial","volume":"130","author":"Wallentin","year":"2014","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C394","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/eurheartj\/ehr454","article-title":"Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation","volume":"33","author":"Raunso","year":"2012","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C395","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1160\/TH14-10-0859","article-title":"Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula","volume":"113","author":"Sjogren","year":"2015","journal-title":"Thromb Haemost"},{"key":"2025110203564805100_ezw313C396","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCULATIONAHA.114.012061","article-title":"Cardiovascular, bleeding, and mortality risks in elderly medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation","volume":"131","author":"Graham","year":"2015","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C397","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT(2)R(2) score","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"key":"2025110203564805100_ezw313C398","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1378\/chest.13-2976","article-title":"Relationship of the SAMe-TT(2)R(2) score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation","volume":"146","author":"Lip","year":"2014","journal-title":"Chest"},{"key":"2025110203564805100_ezw313C399","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.amjmed.2014.05.023","article-title":"SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation","volume":"127","author":"Gallego","year":"2014","journal-title":"Am J Med"},{"key":"2025110203564805100_ezw313C400","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C401","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/europace\/euu225","article-title":"Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011\u20132013","volume":"17","author":"Olesen","year":"2015","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C402","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.jacc.2014.02.549","article-title":"Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes","volume":"63","author":"Hylek","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C403","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1161\/STROKEAHA.112.664144","article-title":"Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial","volume":"43","author":"Flaker","year":"2012","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C404","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMc1007378","article-title":"Newly identified events in the RE-LY trial","volume":"363","author":"Connolly","year":"2010","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C405","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/S0140-6736(14)61943-7","article-title":"Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial","volume":"385","author":"Ruff","year":"2015","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C406","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood-2014-03-563577","article-title":"Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry","volume":"124","author":"Beyer-Westendorf","year":"2014","journal-title":"Blood"},{"key":"2025110203564805100_ezw313C407","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/eurheartj\/ehv466","article-title":"XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation","volume":"37","author":"Camm","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C408","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(10)61194-4","article-title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","volume":"376","author":"Wallentin","year":"2010","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C409","doi-asserted-by":"crossref","first-page":"e000521","DOI":"10.1161\/JAHA.113.000521","article-title":"Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial","volume":"3","author":"Piccini","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2025110203564805100_ezw313C410","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C411","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/STROKEAHA.113.000883","article-title":"Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: A systematic review and meta-analysis","volume":"44","author":"Albertsen","year":"2013","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C412","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2215\/CJN.02400311","article-title":"Warfarin in atrial fibrillation patients with moderate chronic kidney disease","volume":"6","author":"Hart","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025110203564805100_ezw313C413","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/eurheartj\/ehu139","article-title":"Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study","volume":"36","author":"Friberg","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C414","doi-asserted-by":"crossref","first-page":"h246","DOI":"10.1136\/bmj.h246","article-title":"The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study","volume":"350","author":"Jun","year":"2015","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C415","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2015.09.046","article-title":"Meta-Analysis of Renal Function on the Safety and Efficacy of Novel Oral Anticoagulants for Atrial Fibrillation","volume":"117","author":"Del-Carpio Munoz","year":"2016","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C416","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C417","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/ndt\/gfs416","article-title":"Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis","volume":"27","author":"Zimmerman","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2025110203564805100_ezw313C418","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2010.12.013","article-title":"Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk","volume":"57","author":"Marinigh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C419","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ki.2009.477","article-title":"Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy","volume":"77","author":"Wizemann","year":"2010","journal-title":"Kidney Int"},{"key":"2025110203564805100_ezw313C420","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1681\/ASN.2009030319","article-title":"Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation","volume":"20","author":"Chan","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2025110203564805100_ezw313C421","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.2215\/CJN.04550511","article-title":"Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation","volume":"6","author":"Winkelmayer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025110203564805100_ezw313C422","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCULATIONAHA.113.004777","article-title":"Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis","volume":"129","author":"Shah","year":"2014","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C423","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2014.09.051","article-title":"Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study","volume":"64","author":"Bonde","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C424","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.114.014113","article-title":"Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis","volume":"131","author":"Chan","year":"2015","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C425","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.113.003628","article-title":"Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis","volume":"129","author":"Hijazi","year":"2014","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C426","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/eurheartj\/ehr342","article-title":"Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment","volume":"32","author":"Fox","year":"2011","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C427","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1093\/eurheartj\/ehs274","article-title":"Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial","volume":"33","author":"Hohnloser","year":"2012","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C428","first-page":"527","article-title":"Stroke Prevention in Atrial Fibrillation Study","volume":"84","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1991","journal-title":"Final results. Circulation"},{"key":"2025110203564805100_ezw313C429","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1160\/TH11-05-0364","article-title":"Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a \u2018real world\u2019 nationwide cohort study","volume":"106","author":"Olesen","year":"2011","journal-title":"Thromb Haemost"},{"key":"2025110203564805100_ezw313C430","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/europace\/eut333","article-title":"Atrial fibrillation patients do not benefit from acetylsalicylic acid","volume":"16","author":"Sjalander","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C431","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"ACTIVE Writing Group of the ACTIVE Investigators","year":"2006","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C432","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.750000","article-title":"Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range","volume":"118","author":"Connolly","year":"2008","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C433","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C434","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/STROKEAHA.108.526988","article-title":"Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators","volume":"40","author":"van Walraven","year":"2009","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C435","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/hrt.24.3.349","article-title":"The natural history of 271 patients with mitral stenosis under medical treatment","volume":"24","author":"Olesen","year":"1962","journal-title":"Br Heart J"},{"key":"2025110203564805100_ezw313C436","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2004.05.084","article-title":"Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study","volume":"44","author":"Perez-Gomez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C437","doi-asserted-by":"crossref","first-page":"741","DOI":"10.7326\/0003-4819-52-4-741","article-title":"The course of mitral stenosis without surgery: ten- and twenty-year perspectives","volume":"52","author":"Rowe","year":"1960","journal-title":"Ann Intern Med"},{"key":"2025110203564805100_ezw313C438","first-page":"323","article-title":"The natural history of mitral stenosis","volume":"71","author":"Wilson","year":"1954","journal-title":"Can Med Assoc J"},{"key":"2025110203564805100_ezw313C439","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199402173300717","article-title":"Warfarin and aspirin after heart-valve replacement","volume":"330","author":"Cannegieter","year":"1994","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C440","doi-asserted-by":"crossref","first-page":"885","DOI":"10.7326\/0003-4819-128-11-199806010-00001","article-title":"Predictors of systemic embolism in patients with mitral stenosis. A prospective study","volume":"128","author":"Chiang","year":"1998","journal-title":"Ann Intern Med"},{"key":"2025110203564805100_ezw313C441","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review","volume":"1","author":"Wan","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025110203564805100_ezw313C442","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.thromres.2008.09.016","article-title":"Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control","volume":"124","author":"Morgan","year":"2009","journal-title":"Thromb Res"},{"key":"2025110203564805100_ezw313C443","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1160\/TH11-05-0353","article-title":"Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients","volume":"106","author":"Gallagher","year":"2011","journal-title":"Thromb Haemost"},{"key":"2025110203564805100_ezw313C444","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1160\/TH13-06-0443","article-title":"Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis\u2014Task Force on Anticoagulants in Heart Disease","volume":"110","author":"De Caterina","year":"2013","journal-title":"Thromb Haemost"},{"key":"2025110203564805100_ezw313C445","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","article-title":"Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial","volume":"127","author":"Dans","year":"2013","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C446","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jcin.2013.11.010","article-title":"Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies","volume":"7","author":"Bajaj","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203564805100_ezw313C447","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/europace\/euu069","article-title":"Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion","volume":"16","author":"Lewalter","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C448","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/europace\/euu174","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion","volume":"16","author":"Meier","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C449","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C450","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C451","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C452","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C453","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jacc.2015.04.025","article-title":"Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis","volume":"65","author":"Holmes","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C454","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C455","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4244\/EIJY14M10_12","article-title":"Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug","volume":"11","author":"Santoro","year":"2016","journal-title":"EuroIntervention"},{"key":"2025110203564805100_ezw313C456","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCEP.114.001413","article-title":"Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume","volume":"8","author":"Badheka","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C457","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/europace\/euv069","article-title":"Left atrial appendage closure-indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey","volume":"17","author":"Pison","year":"2015","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C458","first-page":"565","article-title":"Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S","volume":"64","author":"Price","year":"2014","journal-title":"transcatheter LAA ligation consortium. J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C459","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","author":"Boersma","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C460","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.2015.0846","article-title":"Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage","volume":"313","author":"Kuramatsu","year":"2015","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C461","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1093\/eurheartj\/ehs290","article-title":"Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and\/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study","volume":"33","author":"Budera","year":"2012","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C462","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ahj.2004.09.054","article-title":"Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke","volume":"150","author":"Healey","year":"2005","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C463","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ejcts\/ezu291","article-title":"Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis","volume":"47","author":"Tsai","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C464","first-page":"1443","article-title":"Left Atrial Appendage Occlusion Study II (LAAOS II)","volume":"29","author":"Whitlock","year":"2013","journal-title":"Can J Cardiol"},{"key":"2025110203564805100_ezw313C465","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.hrthm.2015.03.028","article-title":"Association between incomplete surgical ligation of left atrial appendage and stroke and systemic embolization","volume":"12","author":"Aryana","year":"2015","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C466","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1056\/NEJMoa1500528","article-title":"Surgical ablation of atrial fibrillation during mitral-valve surgery","volume":"372","author":"Gillinov","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C467","first-page":"45","article-title":"Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III","volume":"3","author":"Whitlock","year":"2014","journal-title":"Ann Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C468","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCULATIONAHA.111.074047","article-title":"Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial","volume":"125","author":"Boersma","year":"2012","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C469","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/hs1101.098524","article-title":"Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank","volume":"32","author":"Grau","year":"2001","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C470","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S1474-4422(07)70274-0","article-title":"Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis","volume":"6","author":"Giles","year":"2007","journal-title":"Lancet Neurol"},{"key":"2025110203564805100_ezw313C471","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C472","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1586\/14737175.2014.945435","article-title":"Anti-thrombotic therapy in patients with atrial fibrillation and intracranial hemorrhage","volume":"14","author":"Diener","year":"2014","journal-title":"Expert Rev Neurother"},{"key":"2025110203564805100_ezw313C473","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/ijs.12295","article-title":"Management of acute stroke in patients taking novel oral anticoagulants","volume":"9","author":"Hankey","year":"2014","journal-title":"Int J Stroke"},{"key":"2025110203564805100_ezw313C474","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1001\/jama.2012.6756","article-title":"Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator","volume":"307","author":"Xian","year":"2012","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C475","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for Dabigatran Reversal","volume":"373","author":"Pollack","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C476","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2015.13767","article-title":"Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis","volume":"314","author":"Badhiwala","year":"2015","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C477","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.STR.0000254600.92975.1f","article-title":"Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials","volume":"38","author":"Paciaroni","year":"2007","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C478","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/europace\/eut083","article-title":"European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation","volume":"15","author":"Heidbuchel","year":"2013","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C479","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S1474-4422(10)70274-X","article-title":"Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial","volume":"9","author":"Diener","year":"2010","journal-title":"Lancet Neurol"},{"key":"2025110203564805100_ezw313C480","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1474-4422(12)70042-X","article-title":"Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF","volume":"11","author":"Hankey","year":"2012","journal-title":"Lancet Neurol"},{"key":"2025110203564805100_ezw313C481","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1474-4422(12)70092-3","article-title":"Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial","volume":"11","author":"Easton","year":"2012","journal-title":"Lancet Neurol"},{"key":"2025110203564805100_ezw313C482","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1161\/STROKEAHA.112.673558","article-title":"Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials","volume":"43","author":"Ntaios","year":"2012","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C483","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH13-08-0667","article-title":"Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation?","volume":"111","author":"Paciaroni","year":"2014","journal-title":"Thromb Haemost"},{"key":"2025110203564805100_ezw313C484","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.115.015735","article-title":"Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study","volume":"132","author":"Nielsen","year":"2015","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C485","first-page":"519","article-title":"Antiplatelet therapy in cerebrovascular disorders","volume":"2012","author":"Weber","journal-title":"Handb Exp Pharmacol"},{"key":"2025110203564805100_ezw313C486","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ahj.2006.06.024","article-title":"Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials","volume":"152","author":"Flaker","year":"2006","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C487","first-page":"33","article-title":"Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study","volume":"28","author":"Yung","year":"2012","journal-title":"Can J Cardiol"},{"key":"2025110203564805100_ezw313C488","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/europace\/eut001","article-title":"Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies","volume":"15","author":"Roskell","year":"2013","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C489","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C490","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.110.004747","article-title":"Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial","volume":"123","author":"Eikelboom","year":"2011","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C491","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2013.11.013","article-title":"Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)","volume":"63","author":"Goodman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C492","doi-asserted-by":"crossref","first-page":"h1585","DOI":"10.1136\/bmj.h1585","article-title":"Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study","volume":"350","author":"Chang","year":"2015","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C493","doi-asserted-by":"crossref","first-page":"h1857","DOI":"10.1136\/bmj.h1857","article-title":"Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study","volume":"350","author":"Abraham","year":"2015","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C494","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamacardio.2016.0199","article-title":"Outcomes in a Warfarin-Treated Population With Atrial Fibrillation","volume":"1","author":"Bj\u00f6rck","year":"2016","journal-title":"JAMA Cardiology"},{"key":"2025110203564805100_ezw313C495","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjopharm.2009.06.002","article-title":"Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and\/or early-stage dementia: a single-center, retrospective, observational study","volume":"7","author":"Jacobs","year":"2009","journal-title":"Am J Geriatr Pharmacother"},{"key":"2025110203564805100_ezw313C496","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.amjmed.2014.05.035","article-title":"Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project","volume":"127","author":"Banerjee","year":"2014","journal-title":"Am J Med"},{"key":"2025110203564805100_ezw313C497","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1160\/TH08-11-0730","article-title":"Bleeding with anticoagulation therapy \u2013 who is at risk, and how best to identify such patients","volume":"102","author":"Palareti","year":"2009","journal-title":"Thromb Haemost"},{"key":"2025110203564805100_ezw313C498","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2217\/pgs.09.125","article-title":"Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design","volume":"10","author":"van Schie","year":"2009","journal-title":"Pharmacogenomics"},{"key":"2025110203564805100_ezw313C499","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa0809329","article-title":"Estimation of the warfarin dose with clinical and pharmacogenetic data","volume":"360","author":"International Warfarin Pharmacogenetics Consortium","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C500","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa0708078","article-title":"Genetic determinants of response to warfarin during initial anticoagulation","volume":"358","author":"Schwarz","year":"2008","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C501","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1074248414565666","article-title":"Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials","volume":"20","author":"Tang","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2025110203564805100_ezw313C502","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C503","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jacc.2014.05.065","article-title":"Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants","volume":"64","author":"Cuker","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C504","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv676","article-title":"Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis","author":"Niessner","year":"2015","journal-title":"Eur Heart J;doi:10.1093\/eurheartj\/ehv676. Published online ahead of print 24 December"},{"key":"2025110203564805100_ezw313C505","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/jcp.2003.008904","article-title":"Warfarin reversal","volume":"57","author":"Hanley","year":"2004","journal-title":"J Clin Pathol"},{"key":"2025110203564805100_ezw313C506","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.24416","article-title":"Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage","volume":"78","author":"Parry-Jones","year":"2015","journal-title":"Ann Neurol"},{"key":"2025110203564805100_ezw313C507","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(14)61685-8","article-title":"Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial","volume":"385","author":"Goldstein","year":"2015","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C508","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa1510991","article-title":"Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity","volume":"373","author":"Siegal","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C509","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/ATVBAHA.114.303402","article-title":"Antidotes for novel oral anticoagulants: current status and future potential","volume":"35","author":"Crowther","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025110203564805100_ezw313C510","doi-asserted-by":"crossref","first-page":"h5876","DOI":"10.1136\/bmj.h5876","article-title":"Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study","volume":"351","author":"Staerk","year":"2015","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C511","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.jhh.1001807","article-title":"Antithrombotic therapy in hypertension: a Cochrane Systematic review","volume":"19","author":"Felmeden","year":"2005","journal-title":"J Hum Hypertens"},{"key":"2025110203564805100_ezw313C512","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/CIRCULATIONAHA.114.013267","article-title":"Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis","volume":"132","author":"Sharma","year":"2015","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C513","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2007.11.035","article-title":"Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis","volume":"51","author":"Ruiz-Nodar","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C514","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med"},{"key":"2025110203564805100_ezw313C515","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study","volume":"126","author":"Lamberts","year":"2012","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C516","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C517","doi-asserted-by":"crossref","first-page":"e637S","DOI":"10.1378\/chest.11-2306","article-title":"Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Vandvik","year":"2012","journal-title":"Chest"},{"key":"2025110203564805100_ezw313C518","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1160\/th14-08-0681","article-title":"The optimal management of patients on oral anticoagulation undergoing coronary artery stenting","volume":"112","author":"Rubboli","year":"2014","journal-title":"The 10th Anniversary Overview. Thromb Haemost"},{"key":"2025110203564805100_ezw313C519","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/eurheartj\/eht049","article-title":"New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis","volume":"34","author":"Oldgren","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C520","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/eurheartj\/ehu298","article-title":"Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)","volume":"35","author":"Lip","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C521","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(09)60738-8","article-title":"Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial","volume":"374","author":"Mega","year":"2009","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C522","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2013.02.036","article-title":"Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation","volume":"61","author":"Sarafoff","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C523","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.jcin.2015.08.018","article-title":"Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study","volume":"8","author":"Jackson","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203564805100_ezw313C524","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C525","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.thromres.2014.10.016","article-title":"Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome","volume":"135","author":"Braun","year":"2015","journal-title":"Thromb Res"},{"key":"2025110203564805100_ezw313C526","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/pgmj.2008.068908","article-title":"Chronic atrial fibrillation: a systematic review of medical heart rate control management","volume":"85","author":"Nikolaidou","year":"2009","journal-title":"Postgrad Med J"},{"key":"2025110203564805100_ezw313C527","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0733-8651(03)00111-5","article-title":"Pharmacological rate control of atrial fibrillation","volume":"22","author":"Tamariz","year":"2004","journal-title":"Cardiol Clin"},{"key":"2025110203564805100_ezw313C528","first-page":"47","article-title":"The evidence regarding the drugs used for ventricular rate control","volume":"49","author":"Segal","journal-title":"In. J Fam Practice 2000;"},{"key":"2025110203564805100_ezw313C529","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0196-0644(97)70319-6","article-title":"Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin","volume":"29","author":"Schreck","year":"1997","journal-title":"Ann Emerg Med"},{"key":"2025110203564805100_ezw313C530","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1097\/CCM.0b013e3181a02f56","article-title":"Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation","volume":"37","author":"Siu","year":"2009","journal-title":"Crit Care Med"},{"key":"2025110203564805100_ezw313C531","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-8703(98)70031-6","article-title":"A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery","volume":"135","author":"Tisdale","year":"1998","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C532","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/acem.12091","article-title":"Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness","volume":"20","author":"Scheuermeyer","year":"2013","journal-title":"Acad Emerg Med"},{"key":"2025110203564805100_ezw313C533","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/CIRCULATIONAHA.111.019935","article-title":"Management of atrial fibrillation in patients with structural heart disease","volume":"125","author":"Darby","year":"2012","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C534","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000047278","article-title":"Calcium channel blockers in heart failure","volume":"89","author":"Elkayam","year":"1998","journal-title":"Cardiology"},{"key":"2025110203564805100_ezw313C535","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.83.1.52","article-title":"Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group","volume":"83","author":"Goldstein","year":"1991","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C536","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0002-9149(97)00962-4","article-title":"Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias","volume":"81","author":"Clemo","year":"1998","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C537","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00003246-200106000-00011","article-title":"Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias","volume":"29","author":"Delle Karth","year":"2001","journal-title":"Crit Care Med"},{"key":"2025110203564805100_ezw313C538","first-page":"521","article-title":"Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone","volume":"16","author":"Hou","year":"1995","journal-title":"A randomized, digoxin-controlled study. Eur Heart J"},{"key":"2025110203564805100_ezw313C539","author":"National Institute for Health and Care Excellence (NICE) guidelines"},{"key":"2025110203564805100_ezw313C540","doi-asserted-by":"crossref","first-page":"i1855","DOI":"10.1136\/bmj.i1855","article-title":"Effect of age and sex on efficacy and tolerability of \u03b2 blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis","volume":"353","author":"Kotecha","year":"2016","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C541","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.amjcard.2012.09.020","article-title":"Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation","volume":"111","author":"Ulimoen","year":"2013","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C542","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/eurheartj\/eht429","article-title":"Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation","volume":"35","author":"Ulimoen","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C543","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamainternmed.2013.10432","article-title":"Digitalis use in contemporary clinical practice: refitting the foxglove","volume":"174","author":"Goldberger","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025110203564805100_ezw313C544","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"The Digitalis Investigation Group","year":"1997","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C545","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","article-title":"Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial","volume":"114","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C546","article-title":"Digoxin: The good and the bad","author":"Ziff","journal-title":"Trends in Cardiovascular Medicine"},{"key":"2025110203564805100_ezw313C547","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jacc.2014.03.060","article-title":"Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study","volume":"64","author":"Turakhia","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C548","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00228-007-0346-9","article-title":"Digoxin and mortality in atrial fibrillation: a prospective cohort study","volume":"63","author":"Hallberg","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"2025110203564805100_ezw313C549","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/eurheartj\/ehs348","article-title":"Increased mortality among patients taking digoxin\u2014analysis from the AFFIRM study","volume":"34","author":"Whitbeck","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C550","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/eurheartj\/eht120","article-title":"Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial","volume":"34","author":"Gheorghiade","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C551","doi-asserted-by":"crossref","first-page":"e000888","DOI":"10.1136\/bmjopen-2012-000888","article-title":"Observational cohort study of the safety of digoxin use in women with heart failure","volume":"2","author":"Flory","year":"2012","journal-title":"BMJ Open"},{"key":"2025110203564805100_ezw313C552","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1742-1241.2011.02771.x","article-title":"Mortality and morbidity of heart failure treated with digoxin","volume":"65","author":"Andrey","year":"2011","journal-title":"A propensity-matched study. Int J Clin Pract"},{"key":"2025110203564805100_ezw313C553","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jacc.2015.04.045","article-title":"Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort","volume":"65","author":"Allen","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C554","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.jacc.2003.07.020","article-title":"Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?","volume":"42","author":"Khand","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C555","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0735-1097(98)00561-0","article-title":"Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens","volume":"33","author":"Farshi","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C556","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9149(99)80538-4","article-title":"Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation","volume":"75","author":"Koh","year":"1995","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C557","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005344-198901000-00002","article-title":"Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation","volume":"13","author":"Lewis","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"2025110203564805100_ezw313C558","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1253\/circj.70.965","article-title":"Rate control and quality of life in patients with permanent atrial fibrillation: the Quality of Life and Atrial Fibrillation (QOLAF) Study","volume":"70","author":"Tsuneda","year":"2006","journal-title":"Circ J"},{"key":"2025110203564805100_ezw313C559","article-title":"Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)","author":"ClinicalTrials.gov"},{"key":"2025110203564805100_ezw313C560","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C561","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jacc.2011.06.055","article-title":"The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study","volume":"58","author":"Groenveld","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C562","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/europace\/eul106","article-title":"Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies","volume":"8","author":"Van Gelder","year":"2006","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C563","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/heart.89.9.1035","article-title":"Ablate and pace revisited: long term survival and predictors of permanent atrial fibrillation","volume":"89","author":"Queiroga","year":"2003","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C564","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/europace\/eum091","article-title":"Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trial","volume":"9","author":"Lim","year":"2007","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C565","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1540-8159.1997.tb06179.x","article-title":"Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction","volume":"20","author":"Geelen","year":"1997","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C566","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.hrthm.2013.01.021","article-title":"Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation","volume":"10","author":"Wang","year":"2013","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C567","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCEP.111.967810","article-title":"Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review","volume":"5","author":"Chatterjee","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C568","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.clpt.6100062","article-title":"Overview of management of atrial fibrillation in symptomatic elderly patients: pharmacologic therapy versus AV node ablation","volume":"81","author":"Bradley","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"2025110203564805100_ezw313C569","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/01.CIR.101.10.1138","article-title":"Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis","volume":"101","author":"Wood","year":"2000","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C570","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM200104053441403","article-title":"Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation","volume":"344","author":"Ozcan","year":"2001","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C571","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11886-012-0330-6","article-title":"Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis","volume":"15","author":"Hess","year":"2013","journal-title":"Curr Cardiol Rep"},{"key":"2025110203564805100_ezw313C572","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/CIRCULATIONAHA.106.614560","article-title":"Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure","volume":"114","author":"Hoppe","year":"2006","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C573","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","article-title":"2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C574","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/eurjhf\/hfs036","article-title":"Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis of biventricular vs. right ventricular pacing mode","volume":"14","author":"Chatterjee","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2025110203564805100_ezw313C575","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/eurheartj\/9.7.777","article-title":"Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem","volume":"9","author":"Lewis","year":"1988","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C576","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.hrthm.2014.06.007","article-title":"Digoxin in patients with permanent atrial fibrillation: data from the RACE II study","volume":"11","author":"Mulder","year":"2014","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C577","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0167-5273(95)02480-K","article-title":"Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study","volume":"52","author":"Koh","year":"1995","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C578","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1540-8159.2012.03513.x","article-title":"Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis","volume":"36","author":"Chatterjee","year":"2013","journal-title":"PACE"},{"key":"2025110203564805100_ezw313C579","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archinte.165.3.258","article-title":"Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis","volume":"165","author":"de Denus","year":"2005","journal-title":"Arch Intern Med"},{"key":"2025110203564805100_ezw313C580","first-page":"CD005049","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","volume":"5","author":"Lafuente-Lafuente","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203564805100_ezw313C581","first-page":"913","article-title":"Amiodarone to prevent recurrence of atrial fibrillation","volume":"342","author":"Roy","year":"2000","journal-title":"Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med"},{"key":"2025110203564805100_ezw313C582","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C583","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh","year":"2007","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C584","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(12)60570-4","article-title":"Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial","volume":"380","author":"Kirchhof","year":"2012","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C585","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation","volume":"367","author":"Cosedis Nielsen","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C586","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C587","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/eurheartj\/ehu001","article-title":"The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association","volume":"35","author":"Arbelo","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C588","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C589","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C590","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C591","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.126.2.476","article-title":"Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study","volume":"126","author":"Opolski","year":"2004","journal-title":"Chest"},{"key":"2025110203564805100_ezw313C592","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1542-474X.2010.00365.x","article-title":"Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?","volume":"15","author":"Kong","year":"2010","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2025110203564805100_ezw313C593","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ebmed-2014-110062","article-title":"Rate and rhythm control have comparable effects on mortality and stroke in atrial fibrillation but better data are needed","volume":"19","author":"Kotecha","year":"2014","journal-title":"Evid Based Med"},{"key":"2025110203564805100_ezw313C594","article-title":"Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA)","author":"ClinicalTrials.gov"},{"key":"2025110203564805100_ezw313C595","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-5273(02)00467-9","article-title":"Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation","volume":"87","author":"Khan","year":"2003","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C596","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0735-1097(02)02705-5","article-title":"Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis","volume":"41","author":"Chevalier","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C597","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.163.7.777","article-title":"Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis","volume":"163","author":"Letelier","year":"2003","journal-title":"Arch Intern Med"},{"key":"2025110203564805100_ezw313C598","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0167-5273(02)00477-1","article-title":"Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation","volume":"89","author":"Khan","year":"2003","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C599","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1016\/S0002-8703(03)00526-X","article-title":"Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial","volume":"147","author":"Thomas","year":"2004","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C600","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ahj.2005.09.009","article-title":"A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned","volume":"151","author":"Vijayalakshmi","year":"2006","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C601","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C602","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.107.723866","article-title":"Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial","volume":"117","author":"Roy","year":"2008","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C603","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCEP.109.870204","article-title":"Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial","volume":"2","author":"Kowey","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C604","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jacc.2010.07.046","article-title":"A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation","volume":"57","author":"Camm","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C605","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10557-012-6374-4","article-title":"Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation","volume":"26","author":"Bash","year":"2012","journal-title":"Cardiovasc Drugs Ther"},{"key":"2025110203564805100_ezw313C606","first-page":"385","article-title":"Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter","volume":"29","author":"Falk","year":"1997","journal-title":"Intravenous Dofetilide Investigators. J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C607","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000151703","article-title":"Treatment of stable atrial fibrillation in the emergency department: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management","volume":"112","author":"Dankner","year":"2009","journal-title":"Cardiology"},{"key":"2025110203564805100_ezw313C608","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/0300060513489800","article-title":"Comparison of pharmacological and electrical cardioversion in permanent atrial fibrillation after prosthetic cardiac valve replacement: a prospective randomized trial","volume":"41","author":"Chen","year":"2013","journal-title":"J Int Med Res"},{"key":"2025110203564805100_ezw313C609","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00392-013-0586-x","article-title":"Types and outcomes of cardioversion in patients admitted to hospital for atrial fibrillation: results of the German RHYTHM-AF Study","volume":"102","author":"Gitt","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"2025110203564805100_ezw313C610","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/emj.2009.083196","article-title":"Cardioversion of acute atrial fibrillation in the short observation unit: comparison of a protocol focused on electrical cardioversion with simple antiarrhythmic treatment","volume":"28","author":"Cristoni","year":"2011","journal-title":"Emerg Med J"},{"key":"2025110203564805100_ezw313C611","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/emj.2010.109702","article-title":"Cardioversion of acute atrial fibrillation in the emergency department: a prospective randomised trial","volume":"29","author":"Bellone","year":"2012","journal-title":"Emerg Med J"},{"key":"2025110203564805100_ezw313C612","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijcard.2014.01.099","article-title":"Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study","volume":"172","author":"Crijns","year":"2014","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C613","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.amjcard.2013.10.036","article-title":"Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study)","volume":"113","author":"Lip","year":"2014","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C614","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ehj.2004.04.030","article-title":"Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset","volume":"25","author":"Reisinger","year":"2004","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C615","first-page":"1613","article-title":"Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation","volume":"94","author":"Stambler","year":"1996","journal-title":"Ibutilide Repeat Dose Study Investigators. Circulation"},{"key":"2025110203564805100_ezw313C616","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2011.10.108","article-title":"Vernakalant: conversion of atrial fibrillation in patients with ischemic heart disease","volume":"166","author":"Torp-Pedersen","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C617","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/europace\/eut274","article-title":"Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines","volume":"16","author":"Savelieva","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C618","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euw052","article-title":"Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department","author":"Simon","year":"2016","journal-title":"Europace;doi:10.1093\/europace\/euw052. Published online ahead of print 22 March"},{"key":"2025110203564805100_ezw313C619","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0002-9149(98)00223-9","article-title":"Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation","volume":"81","author":"Reisinger","year":"1998","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C620","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1056\/NEJMoa041233","article-title":"Outpatient treatment of recent-onset atrial fibrillation with the \"pill-in-the-pocket\" approach","volume":"351","author":"Alboni","year":"2004","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C621","article-title":"Systematic review and cost-effectiveness evaluation of \u2018pill-in-the-pocket\u2019 strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy","volume":"14","author":"Saborido","year":"2010","journal-title":"Health Technol Assess"},{"key":"2025110203564805100_ezw313C622","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0735-1097(00)01116-5","article-title":"Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation","volume":"37","author":"Khan","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C623","first-page":"418","article-title":"Propafenone for conversion and prophylaxis of atrial fibrillation","volume":"79","author":"Stroobandt","year":"1997","journal-title":"Propafenone Atrial Fibrillation Trial Investigators. Am J Cardiol"},{"key":"2025110203564805100_ezw313C624","first-page":"839","article-title":"Oral propafenone for rapid conversion of recent onset atrial fibrillation\u2014A review","volume":"13","author":"Hughes","year":"1997","journal-title":"Can J Cardiol"},{"key":"2025110203564805100_ezw313C625","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1368-5031.2005.00705.x","article-title":"Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation","volume":"59","author":"Zhang","year":"2005","journal-title":"Int J Clin Pract"},{"key":"2025110203564805100_ezw313C626","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/01.CIR.101.11.1282","article-title":"Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks","volume":"101","author":"Mittal","year":"2000","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C627","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(02)11315-8","article-title":"Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial","volume":"360","author":"Kirchhof","year":"2002","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C628","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/eurheartj\/ehi160","article-title":"A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA)","volume":"26","author":"Kirchhof","year":"2005","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C629","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1136\/heartjnl-2015-307656","article-title":"Safe sedation in modern cardiological practice","volume":"101","author":"Furniss","year":"2015","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C630","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0167-5273(00)00326-0","article-title":"Randomised comparison of antero-lateral versus antero-posterior paddle positions for DC cardioversion of persistent atrial fibrillation","volume":"75","author":"Alp","year":"2000","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C631","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.hrthm.2008.10.036","article-title":"Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial","volume":"6","author":"Singh","year":"2009","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C632","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ehj.2003.10.020","article-title":"A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation","volume":"25","author":"Channer","year":"2004","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C633","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJM199906173402401","article-title":"Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment","volume":"340","author":"Oral","year":"1999","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C634","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/europace\/euv194","article-title":"Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion","volume":"18","author":"Mussigbrodt","year":"2016","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C635","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0735-1097(96)00230-6","article-title":"Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study","volume":"28","author":"Bianconi","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C636","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/eurheartj\/ehl544","article-title":"Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study","volume":"28","author":"Nergardh","year":"2007","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C637","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2006.05.043","article-title":"Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation","volume":"48","author":"Hemels","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C638","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1067\/mhj.2000.107179","article-title":"Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study","volume":"140","author":"Villani","year":"2000","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C639","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0735-1097(99)00256-9","article-title":"Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion","volume":"34","author":"De Simone","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C640","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/oxfordjournals.eurheartj.a015311","article-title":"Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients","volume":"18","author":"The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group","year":"1997","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C641","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1253\/circj.66.553","article-title":"Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation","volume":"66","author":"Atarashi","year":"2002","journal-title":"Circ J"},{"key":"2025110203564805100_ezw313C642","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2013.04.089","article-title":"Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study","volume":"62","author":"Airaksinen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C643","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/europace\/euu189","article-title":"Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy","volume":"17","author":"Hansen","year":"2015","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C644","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00129784-200707030-00006","article-title":"Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany","volume":"7","author":"Schadlich","year":"2007","journal-title":"Am J Cardiovasc Drugs"},{"key":"2025110203564805100_ezw313C645","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2005.11.016","article-title":"Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial","volume":"119","author":"Schmidt-Lucke","year":"2007","journal-title":"Thromb Res"},{"key":"2025110203564805100_ezw313C646","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/01.CIR.0000120509.64740.DC","article-title":"Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial","volume":"109","author":"Stellbrink","year":"2004","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C647","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/jama.2014.3824","article-title":"Time to cardioversion for acute atrial fibrillation and thromboembolic complications","volume":"312","author":"Nuotio","year":"2014","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C648","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","article-title":"Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C649","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1093\/eurheartj\/ehu367","article-title":"Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation","volume":"35","author":"Cappato","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C650","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/eurheartj\/ehu354","article-title":"Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial)","volume":"35","author":"Darkner","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C651","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure","volume":"333","author":"Singh","year":"1995","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C652","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jacc.2009.03.043","article-title":"Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation","volume":"54","author":"Kirchhof","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C653","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.hrthm.2007.07.020","article-title":"A practical guide for clinicians who treat patients with amiodarone: 2007","volume":"4","author":"Goldschlager","year":"2007","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C654","first-page":"43","article-title":"Amiodarone pulmonary toxicity","volume":"16","author":"Wolkove","year":"2009","journal-title":"Can Respir J"},{"key":"2025110203564805100_ezw313C655","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.300.15.1784","article-title":"Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial","volume":"300","author":"Ahmed","year":"2008","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C656","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ahj.2008.06.010","article-title":"Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study","volume":"156","author":"Davy","year":"2008","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C657","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C658","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C659","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2125.2007.02998.x","article-title":"Effect of dronedarone on renal function in healthy subjects","volume":"64","author":"Tschuppert","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"2025110203564805100_ezw313C660","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","author":"The Cardiac Arrhythmia Suppression Trial (CAST) Investigators","year":"1989","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C661","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/europace\/euq450","article-title":"Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation","volume":"13","author":"Freemantle","year":"2011","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C662","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C663","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1378\/chest.07-1188","article-title":"Oral disopyramide for the acute treatment of severe outflow obstruction in hypertrophic cardiomyopathy in the ICU setting","volume":"133","author":"Sirak","year":"2008","journal-title":"Chest"},{"key":"2025110203564805100_ezw313C664","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCHEARTFAILURE.112.000122","article-title":"Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with beta-blockade or verapamil","volume":"6","author":"Sherrid","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2025110203564805100_ezw313C665","first-page":"7","article-title":"Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators","volume":"348","author":"Waldo","year":"1996","journal-title":"Survival With Oral d-Sotalol. Lancet"},{"key":"2025110203564805100_ezw313C666","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.104.3.292","article-title":"Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy","volume":"104","author":"Pedersen","year":"2001","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C667","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/europace\/eup293","article-title":"Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation","volume":"11","author":"Shamiss","year":"2009","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C668","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0008-6363(00)00119-X","article-title":"The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology","volume":"47","author":"Haverkamp","year":"2000","journal-title":"Cardiovasc Res"},{"key":"2025110203564805100_ezw313C669","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0195-668X(02)00806-0","article-title":"Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome-a case-control pilot study using i.v. sotalol","volume":"24","author":"K\u00e4\u00e4b","year":"2003","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C670","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1742-7843.2010.00547.x","article-title":"Predictable and less predictable unwanted cardiac drugs effects: individual pre-disposition and transient precipitating factors","volume":"106","author":"Fabritz","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2025110203564805100_ezw313C671","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0735-1097(99)00226-0","article-title":"Exaggerated QT prolongation after cardioversion of atrial fibrillation","volume":"34","author":"Choy","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C672","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ehj.2004.06.014","article-title":"Suppression of paroxysmal atrial tachyarrhythmias\u2014results of the SOPAT trial","volume":"25","author":"Patten","year":"2004","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C673","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/FJC.0b013e31824e1b93","article-title":"Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity","volume":"59","author":"Burashnikov","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"2025110203564805100_ezw313C674","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/FJC.0b013e31828780eb","article-title":"Human electrophysiological and pharmacological properties of XEN-D0101: a novel atrial-selective Kv1.5\/IKur inhibitor","volume":"61","author":"Ford","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"2025110203564805100_ezw313C675","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fphar.2014.00026","article-title":"Effects of IKur blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation","volume":"5","author":"Loose","year":"2014","journal-title":"Front Pharmacol"},{"key":"2025110203564805100_ezw313C676","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.bjp.0705879","article-title":"Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects","volume":"142","author":"Schram","year":"2004","journal-title":"Br J Pharmacol"},{"key":"2025110203564805100_ezw313C677","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.CIR.93.1.135","article-title":"Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts","volume":"93","author":"McCormack","year":"1996","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C678","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.107.724880","article-title":"Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial","volume":"116","author":"Scirica","year":"2007","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C679","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/europace\/euu217","article-title":"Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial","volume":"17","author":"Scirica","year":"2015","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C680","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/CIRCEP.115.002856","article-title":"The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism","volume":"8","author":"Reiffel","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C681","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.amjcard.2012.04.044","article-title":"Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation","volume":"110","author":"Fragakis","year":"2012","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C682","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/0003319713477911","article-title":"Ranolazine enhances the antiarrhythmic activity of amiodarone by accelerating conversion of new-onset atrial fibrillation after cardiac surgery","volume":"65","author":"Simopoulos","year":"2014","journal-title":"Angiology"},{"key":"2025110203564805100_ezw313C683","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/europace\/eut407","article-title":"Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation","volume":"16","author":"Koskinas","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C684","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.hrthm.2015.01.021","article-title":"Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study","volume":"12","author":"De Ferrari","year":"2015","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C685","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/heartjnl-2014-305482","article-title":"Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials","volume":"100","author":"Martin","year":"2014","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C686","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.296.10.1242","article-title":"Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension","volume":"296","author":"Okin","year":"2006","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C687","first-page":"610","article-title":"Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines","volume":"13","author":"Savelieva","year":"2011","journal-title":"Part II: secondary prevention. Europace"},{"key":"2025110203564805100_ezw313C688","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0735-1097(00)00693-8","article-title":"Use of metoprolol CR\/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study","volume":"36","author":"Kuhlkamp","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C689","first-page":"Cd008493","article-title":"Preoperative statin therapy for patients undergoing cardiac surgery","volume":"4","author":"Liakopoulos","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203564805100_ezw313C690","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ejcts\/ezt181","article-title":"Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients","volume":"45","author":"Kuhn","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C691","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMoa1507750","article-title":"Perioperative Rosuvastatin in Cardiac Surgery","volume":"374","author":"Zheng","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C692","doi-asserted-by":"crossref","first-page":"d1250","DOI":"10.1136\/bmj.d1250","article-title":"Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials","volume":"342","author":"Rahimi","year":"2011","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C693","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1089\/ars.2013.5542","article-title":"Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins","volume":"20","author":"Pinho-Gomes","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"2025110203564805100_ezw313C694","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/europace\/euq386","article-title":"n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study","volume":"13","author":"Bianconi","year":"2011","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C695","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.2010.1735","article-title":"Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial","volume":"304","author":"Kowey","year":"2010","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C696","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.2012.28733","article-title":"Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial","volume":"308","author":"Mozaffarian","year":"2012","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C697","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/europace\/euq439","article-title":"Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study)","volume":"13","author":"Yamashita","year":"2011","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C698","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2012.11.021","article-title":"Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial","volume":"61","author":"Macchia","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C699","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.amjcard.2010.07.037","article-title":"Effect of combined spironolactone-\u03b2-blocker \u00b1 enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a history of paroxysmal atrial fibrillation (SPIR-AF study)","volume":"106","author":"Dabrowski","year":"2010","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C700","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.amjcard.2012.12.020","article-title":"Effect of eplerenone on maintenance of sinus rhythm after catheter ablation in patients with long-standing persistent atrial fibrillation","volume":"111","author":"Ito","year":"2013","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C701","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C702","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0196-0644(03)00510-9","article-title":"Sedation for cardioversion in the emergency department: analysis of effectiveness in four protocols","volume":"42","author":"Coll-Vinent","year":"2003","journal-title":"Ann Emerg Med"},{"key":"2025110203564805100_ezw313C703","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.annemergmed.2005.03.002","article-title":"Analysis of current management of atrial fibrillation in the acute setting: GEFAUR-1 study","volume":"46","author":"del Arco","year":"2005","journal-title":"Ann Emerg Med"},{"key":"2025110203564805100_ezw313C704","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.annemergmed.2010.09.027","article-title":"Emergency department management and 1-year outcomes of patients with atrial flutter","volume":"57","author":"Scheuermeyer","year":"2011","journal-title":"Ann Emerg Med"},{"key":"2025110203564805100_ezw313C705","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0002-8703(98)70150-4","article-title":"Electrical cardioversion of atrial fibrillation or flutter with conscious sedation in the age of cost containment","volume":"136","author":"Goldner","year":"1998","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C706","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0002-9149(00)01128-0","article-title":"Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm","volume":"86","author":"Martinez-Marcos","year":"2000","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C707","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1177\/0091270011426876","article-title":"Efficacy and safety of vernakalant in recent-onset atrial fibrillation after the European medicines agency approval: systematic review and meta-analysis","volume":"52","author":"Buccelletti","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"2025110203564805100_ezw313C708","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1093\/eurheartj\/ehu367","article-title":"Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation","volume":"35","author":"Cappato","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C709","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.110.977546","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion","volume":"123","author":"Nagarakanti","year":"2011","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C710","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/01.CIR.0000118472.77237.FA","article-title":"Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"109","author":"Steinberg","year":"2004","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C711","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(97)03425-9","article-title":"Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome","volume":"350","author":"Andersen","year":"1997","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C712","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJM200005113421902","article-title":"Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators","volume":"342","author":"Connolly","year":"2000","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C713","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C714","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/HJH.0b013e3282f35c67","article-title":"Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial","volume":"26","author":"Schmieder","year":"2008","journal-title":"J Hypertens"},{"key":"2025110203564805100_ezw313C715","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/europace\/eus027","article-title":"2012 HRS\/EHRA\/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design","volume":"14","author":"Calkins","year":"2012","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C716","doi-asserted-by":"crossref","first-page":"e003337","DOI":"10.1161\/CIRCEP.115.003337","article-title":"Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation: Results From the Gap-Atrial Fibrillation-German Atrial Fibrillation Competence Network 1 Trial","volume":"9","author":"Kuck","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C717","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","article-title":"Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)","volume":"35","author":"Mont","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C718","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/CIRCEP.114.001672","article-title":"Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success","volume":"8","author":"Schreiber","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C719","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/CIRCEP.114.001943","article-title":"Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint","volume":"8","author":"Scherr","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C720","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacep.2015.02.018","article-title":"Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials","volume":"1","author":"Al Halabi","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C721","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/europace\/euu376","article-title":"Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis","volume":"17","author":"Hakalahti","year":"2015","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C722","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial","volume":"311","author":"Morillo","year":"2014","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C723","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C724","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJMoa050955","article-title":"Circumferential pulmonary-vein ablation for chronic atrial fibrillation","volume":"354","author":"Oral","year":"2006","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C725","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurheartj\/ehi583","article-title":"Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)","volume":"27","author":"Stabile","year":"2006","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C726","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1540-8167.2008.01275.x","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy","volume":"20","author":"Forleo","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C727","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","article-title":"Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation","volume":"3","author":"Cappato","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C728","doi-asserted-by":"crossref","first-page":"e004549","DOI":"10.1161\/JAHA.112.004549","article-title":"Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis","volume":"2","author":"Ganesan","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2025110203564805100_ezw313C729","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/eurheartj\/ehv139","article-title":"A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: a prospective multi-centre randomized controlled trial (the Minimax study)","volume":"36","author":"McLellan","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2012.04.002","article-title":"Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II (STAR AF II): design and rationale","volume":"164","author":"Verma","year":"2012","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C731","article-title":"Relationship Between Pulmonary Vein Reconnection and Atrial Fibrillation Recurrence","author":"Nery","journal-title":"JACC Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C732","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/CIRCULATIONAHA.115.016871","article-title":"Cryoballoon Versus Open Irrigated Radiofrequency Ablation in Patients With Paroxysmal Atrial Fibrillation: The Prospective, Randomized, Controlled, Noninferiority FreezeAF Study","volume":"132","author":"Luik","year":"2015","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C733","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jce.12267","article-title":"Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry","volume":"25","author":"Schmidt","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C734","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation","volume":"374","author":"Kuck","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C735","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","article-title":"Approaches to catheter ablation for persistent atrial fibrillation","volume":"372","author":"Verma","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C736","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/europace\/euv067","article-title":"Prospective randomized comparison between a fixed \u20182C3L\u2019 approach vs. stepwise approach for catheter ablation of persistent atrial fibrillation","volume":"17","author":"Dong","year":"2015","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C737","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/heartjnl-2011-300720","article-title":"Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death","volume":"98","author":"Hunter","year":"2012","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C738","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/CIRCEP.115.003019","article-title":"Is There Still a Role for Complex Fractionated Atrial Electrogram Ablation in Addition to Pulmonary Vein Isolation in Patients With Paroxysmal and Persistent Atrial Fibrillation? Meta-Analysis of 1415 Patients","volume":"8","author":"Providencia","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C739","article-title":"Impact of Rotor Ablation in Non-Paroxysmal AF Patients: Results from a Randomized Trial (OASIS)","author":"Mohanty","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C740","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/CIRCEP.113.001251","article-title":"Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation","volume":"7","author":"Rolf","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C741","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/CIRCEP.112.971259","article-title":"Prevalence and types of pitfall in the assessment of mitral isthmus linear conduction block","volume":"5","author":"Shah","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C742","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(15)60026-5","article-title":"Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial","volume":"386","author":"Macle","year":"2015","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C743","first-page":"3276","article-title":"Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) trial","volume":"36","author":"Kobori","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C744","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2016.04.016","article-title":"Focal impulse and rotor modulation as a stand-alone procedure for treatment of paroxysmal atrial fibrillation. A within-patient controlled study with implanted cardiac monitoring","author":"Berntsen","year":"2016","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C745","first-page":"163","article-title":"Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center","volume":"22","author":"Lee","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C746","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCEP.114.001759","article-title":"Efficacy of catheter ablation for persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized and nonrandomized controlled trials","volume":"7","author":"Wynn","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C747","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCULATIONAHA.113.004498","article-title":"Shared decision making in atrial fibrillation: where we are and where we should be going","volume":"129","author":"Seaburg","year":"2014","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C748","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1540-8167.2009.01493.x","article-title":"Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern?","volume":"20","author":"Dagres","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C749","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jce.12608","article-title":"Silent cerebral events\/lesions related to atrial fibrillation ablation: a clinical review","volume":"26","author":"Deneke","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C750","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/CIRCEP.113.000768","article-title":"Complications of catheter ablation of atrial fibrillation: a systematic review","volume":"6","author":"Gupta","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C751","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.jacc.2011.09.028","article-title":"Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report","volume":"58","author":"Cappato","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C752","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/STROKEAHA.111.627067","article-title":"Left atrial catheter ablation and ischemic stroke","volume":"43","author":"Haeusler","year":"2012","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C753","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.hrthm.2014.07.039","article-title":"Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors","volume":"11","author":"Kosiuk","year":"2014","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C754","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1540-8167.2011.02050.x","article-title":"Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon","volume":"22","author":"Gaita","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C755","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1111\/j.1540-8159.2005.00062.x","article-title":"Incidence and prevention of cardiac tamponade complicating ablation for atrial fibrillation","volume":"28","author":"Hsu","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C756","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/CIRCEP.113.000760","article-title":"Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation: results from a worldwide survey in 34 943 atrial fibrillation ablation procedures","volume":"7","author":"Michowitz","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C757","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10840-013-9853-z","article-title":"The prevalence and risk factors for atrioesophageal fistula after percutaneous radiofrequency catheter ablation for atrial fibrillation: the Canadian experience","volume":"39","author":"Nair","year":"2014","journal-title":"J Interv Card Electrophysiol"},{"key":"2025110203564805100_ezw313C758","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jacc.2011.08.068","article-title":"Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation","volume":"59","author":"Shah","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C759","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCEP.113.000899","article-title":"Comparison of the first and second cryoballoon: high-volume single-center safety and efficacy analysis","volume":"7","author":"Straube","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C760","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","article-title":"Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management: Results From the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) Randomized Trial","volume":"129","author":"Di Biase","year":"2014","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C761","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.hrthm.2015.02.028","article-title":"Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study","volume":"12","author":"Di Biase","year":"2015","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C762","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/europace\/eut241","article-title":"Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature","volume":"15","author":"Hohnloser","year":"2013","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C763","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2013.11.039","article-title":"Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry","volume":"63","author":"Lakkireddy","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C764","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/europace\/euu007","article-title":"Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation","volume":"16","author":"Providencia","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C765","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10840-014-9888-9","article-title":"Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation","volume":"40","author":"Stepanyan","year":"2014","journal-title":"J Interv Card Electrophysiol"},{"key":"2025110203564805100_ezw313C766","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.amjcard.2014.05.038","article-title":"Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation","volume":"114","author":"Aryal","year":"2014","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C767","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2014.10.005","article-title":"Comparison of safety of left atrial catheter ablation procedures for atrial arrhythmias under continuous anticoagulation with apixaban versus phenprocoumon","volume":"115","author":"Kaess","year":"2015","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C768","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","article-title":"Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation","volume":"36","author":"Cappato","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C769","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.amjcard.2015.12.027","article-title":"Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation","volume":"117","author":"Wu","year":"2016","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C770","doi-asserted-by":"crossref","first-page":"e0126512","DOI":"10.1371\/journal.pone.0126512","article-title":"Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis","volume":"10","author":"Santarpia","year":"2015","journal-title":"PLoS One"},{"key":"2025110203564805100_ezw313C771","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/eurheartj\/ehu421","article-title":"Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark","volume":"36","author":"Karasoy","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C772","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jacc.2009.11.039","article-title":"The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation","volume":"55","author":"Themistoclakis","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C773","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.hrthm.2013.07.002","article-title":"Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score","volume":"10","author":"Bunch","year":"2013","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C774","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.hrthm.2014.08.016","article-title":"Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation","volume":"11","author":"Nedios","year":"2014","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C775","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCOUTCOMES.111.963108","article-title":"Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis","volume":"5","author":"Reynolds","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025110203564805100_ezw313C776","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2459\/JCM.0000000000000311","article-title":"Long-term events following atrial fibrillation rate control or transcatheter ablation: a multicenter observational study","volume":"17","author":"Gallo","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2025110203564805100_ezw313C777","article-title":"Ablation vs. Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial","author":"Di Biase","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C778","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","article-title":"A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial)","volume":"7","author":"Hunter","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C779","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/hrt.2010.207340","article-title":"Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial","volume":"97","author":"MacDonald","year":"2011","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C780","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cardfail.2011.07.009","article-title":"Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis","volume":"17","author":"Dagres","year":"2011","journal-title":"J Card Fail"},{"key":"2025110203564805100_ezw313C781","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1540-8167.2005.00245.x","article-title":"Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation","volume":"16","author":"Piorkowski","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C782","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamainternmed.2013.1561","article-title":"Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study","volume":"173","author":"Verma","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2025110203564805100_ezw313C783","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/jama.1991.03470140088029","article-title":"Successful surgical treatment of atrial fibrillation. Review and clinical update","volume":"266","author":"Cox","year":"1991","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C784","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0022-5223(19)36684-X","article-title":"The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure","volume":"101","author":"Cox","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C785","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jtcvs.2013.10.084","article-title":"Surgical ablation for atrial fibrillation for two decades: are the results of new techniques equivalent to the Cox maze III procedure?","volume":"147","author":"Stulak","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C786","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/icvts\/ivs311","article-title":"How effective is bipolar radiofrequency ablation for atrial fibrillation during concomitant cardiac surgery?","volume":"15","author":"Basu","year":"2012","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203564805100_ezw313C787","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1055\/s-0030-1271146","article-title":"The effect of microwave and bipolar radio-frequency ablation in the surgical treatment of permanent atrial fibrillation during valve surgery","volume":"59","author":"Lin","year":"2011","journal-title":"Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C788","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jtcvs.2009.12.038","article-title":"Where does atrial fibrillation surgery fail? Implications for increasing effectiveness of ablation","volume":"139","author":"McCarthy","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C789","doi-asserted-by":"crossref","first-page":"I20","DOI":"10.1161\/CIRCULATIONAHA.104.526301","article-title":"Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease","volume":"112","author":"Abreu Filho","year":"2005","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C790","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1093\/eurheartj\/ehm378","article-title":"A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF)","volume":"28","author":"Blomstrom-Lundqvist","year":"2007","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C791","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.acvd.2009.08.010","article-title":"Left atrial radiofrequency ablation during mitral valve surgery: a prospective randomized multicentre study (SAFIR)","volume":"102","author":"Chevalier","year":"2009","journal-title":"Arch Cardiovasc Dis"},{"key":"2025110203564805100_ezw313C792","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/euhj.2001.2841","article-title":"Efficacy of an additional MAZE procedure using cooled-tip radiofrequency ablation in patients with chronic atrial fibrillation and mitral valve disease. A randomized, prospective trial","volume":"23","author":"Deneke","year":"2002","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C793","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.294.18.2323","article-title":"Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial","volume":"294","author":"Doukas","year":"2005","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C794","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1010-7940(03)00377-4","article-title":"Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial","volume":"24","author":"Schuetz","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C795","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1093\/eurheartj\/ehq201","article-title":"Efficacy of catheter ablation and surgical CryoMaze procedure in patients with long-lasting persistent atrial fibrillation and rheumatic heart disease: a randomized trial","volume":"31","author":"Liu","year":"2010","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C796","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/imi.0b013e3181d9199b","article-title":"Surgical ablation for atrial fibrillation in cardiac surgery: a meta-analysis and systematic review","volume":"5","author":"Cheng","year":"2010","journal-title":"Innovations (Phila)"},{"key":"2025110203564805100_ezw313C797","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jtcvs.2005.10.020","article-title":"Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis","volume":"131","author":"Barnett","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C798","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/HCO.0b013e32835ced9c","article-title":"The state of surgical ablation for atrial fibrillation in patients with mitral valve disease","volume":"28","author":"Ad","year":"2013","journal-title":"Curr Opin Cardiol"},{"key":"2025110203564805100_ezw313C799","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.athoracsur.2007.10.097","article-title":"Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database","volume":"85","author":"Gammie","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C800","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1378\/chest.125.6.2129","article-title":"Preoperative atrial size predicts the success of radiofrequency maze procedure for permanent atrial fibrillation in patients undergoing concomitant valvular surgery","volume":"125","author":"Chen","year":"2004","journal-title":"Chest"},{"key":"2025110203564805100_ezw313C801","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1510\/icvts.2011.271999","article-title":"What size of left atrium significantly impairs the success of maze surgery for atrial fibrillation?","volume":"13","author":"Sunderland","year":"2011","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203564805100_ezw313C802","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/021849230801600407","article-title":"Predictors of sinus rhythm after radiofrequency maze and mitral valve surgery","volume":"16","author":"Chaiyaroj","year":"2008","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"2025110203564805100_ezw313C803","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.athoracsur.2006.02.030","article-title":"Surgery for permanent atrial fibrillation: impact of patient factors and lesion set","volume":"82","author":"Gillinov","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C804","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ejcts.2008.07.026","article-title":"Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure","volume":"34","author":"Beukema","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C805","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.athoracsur.2005.04.060","article-title":"Surgery for paroxysmal atrial fibrillation in the setting of mitral valve disease: a role for pulmonary vein isolation?","volume":"81","author":"Gillinov","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C806","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2010.09.055","article-title":"Impact of lesion sets on mid-term results of surgical ablation procedure for atrial fibrillation","volume":"57","author":"Onorati","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C807","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.athoracsur.2011.12.028","article-title":"Cox-Maze IV results for patients with lone atrial fibrillation versus concomitant mitral disease","volume":"93","author":"Saint","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C808","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jtcvs.2014.05.064","article-title":"A minimally invasive Cox maze IV procedure is as effective as sternotomy while decreasing major morbidity and hospital stay","volume":"148","author":"Lawrance","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C809","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jtcvs.2009.11.065","article-title":"Pulmonary vein isolation and autonomic denervation for the management of paroxysmal atrial fibrillation by a minimally invasive surgical approach","volume":"140","author":"Edgerton","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C810","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1540-8167.2007.00977.x","article-title":"Preliminary results of a limited thoracotomy: new approach to treat atrial fibrillation","volume":"18","author":"McClelland","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C811","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jtcvs.2009.11.009","article-title":"Thoracoscopic pulmonary vein isolation in patients with atrial fibrillation and failed percutaneous ablation","volume":"140","author":"Castella","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C812","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/CIRCEP.111.961862","article-title":"Thoracoscopic video-assisted pulmonary vein antrum isolation, ganglionated plexus ablation, and periprocedural confirmation of ablation lesions: first results of a hybrid surgical-electrophysiological approach for atrial fibrillation","volume":"4","author":"Krul","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C813","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1749-8090-7-71","article-title":"The hybrid approach for the surgical treatment of lone atrial fibrillation: one-year results employing a monopolar radiofrequency source","volume":"7","author":"La Meir","year":"2012","journal-title":"J Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C814","first-page":"2567","article-title":"Comparative study of video-assisted thoracoscopic surgery ablation and radiofrequency catheter ablation on treating paroxysmal atrial fibrillation: a randomized, controlled short-term trial","volume":"127","author":"Wang","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"2025110203564805100_ezw313C815","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/ejcts\/ezv180","article-title":"Thoracoscopic surgical ablation versus catheter ablation for atrial fibrillation","volume":"49","author":"Phan","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C816","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.jtcvs.2013.10.054","article-title":"Analysis of risk factors for recurrence after video-assisted pulmonary vein isolation of lone atrial fibrillation-results of 5 years of follow-up","volume":"148","author":"Hu","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C817","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.athoracsur.2008.03.071","article-title":"Minimally invasive pulmonary vein isolation and partial autonomic denervation for surgical treatment of atrial fibrillation","volume":"86","author":"Edgerton","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C818","doi-asserted-by":"crossref","first-page":"e22122","DOI":"10.1371\/journal.pone.0022122","article-title":"Minimally invasive surgical versus catheter ablation for the long-lasting persistent atrial fibrillation","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"2025110203564805100_ezw313C819","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ejcts\/ezt593","article-title":"Ablation in selective patients with long-standing persistent atrial fibrillation: medium-term results of the Dallas lesion set","volume":"46","author":"Wang","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C820","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.athoracsur.2012.06.010","article-title":"Interim results of the 5-box thoracoscopic maze procedure","volume":"94","author":"Sirak","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C821","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.athoracsur.2012.01.110","article-title":"Minimally invasive surgery using bipolar radiofrequency energy is effective treatment for refractory atrial fibrillation","volume":"93","author":"Kasirajan","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C822","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.athoracsur.2012.07.035","article-title":"Approaching a paradigm shift: endoscopic ablation of lone atrial fibrillation on the beating heart","volume":"94","author":"Weimar","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C823","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.ijcard.2012.04.044","article-title":"Minimally invasive surgical treatment of lone atrial fibrillation: early results of hybrid versus standard minimally invasive approach employing radiofrequency sources","volume":"167","author":"La Meir","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C824","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/ejcts\/ezt385","article-title":"Hybrid thoracoscopic and transvenous catheter ablation of atrial fibrillation","volume":"45","author":"Gelsomino","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C825","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2011.12.055","article-title":"Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation","volume":"60","author":"Pison","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C826","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/europace\/eut208","article-title":"Surgical vs. transcatheter pulmonary vein isolation as first invasive treatment in patients with atrial fibrillation: a matched group comparison","volume":"16","author":"De Maat","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C827","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1136\/heartjnl-2015-307550","article-title":"Atrial flutter and thromboembolic risk: a systematic review","volume":"101","author":"Vadmann","year":"2015","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C828","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.athoracsur.2006.03.075","article-title":"Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the Cox-maze procedure significantly improves systolic function and functional status","volume":"82","author":"Stulak","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C829","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/pace.12340","article-title":"Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome?","volume":"37","author":"Chen","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C830","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1540-8167.2004.03279.x","article-title":"Pulmonary vein isolation for atrial fibrillation in patients with symptomatic sinus bradycardia or pauses","volume":"15","author":"Khaykin","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C831","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.semtcvs.2012.04.007","article-title":"Current role for surgery in treatment of lone atrial fibrillation","volume":"24","author":"Ad","year":"2012","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C832","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCEP.111.963819","article-title":"The cox-maze procedure for lone atrial fibrillation: a single-center experience over 2 decades","volume":"5","author":"Weimar","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C833","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jtcvs.2011.12.018","article-title":"Do we increase the operative risk by adding the Cox Maze III procedure to aortic valve replacement and coronary artery bypass surgery?","volume":"143","author":"Ad","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C834","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1015319618049","article-title":"Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs (\"hybrid therapy\") improves rhythm control in patients with refractory atrial fibrillation","volume":"6","author":"Prakash","year":"2002","journal-title":"J Interv Card Electrophysiol"},{"key":"2025110203564805100_ezw313C835","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1540-8167.1999.tb00293.x","article-title":"Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction","volume":"10","author":"Tai","year":"1999","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C836","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0735-1097(01)01214-1","article-title":"Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation","volume":"37","author":"Stabile","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C837","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10840-012-9679-0","article-title":"Nearly uniform failure of atrial flutter ablation and continuation of antiarrhythmic agents (hybrid therapy) for the long-term control of atrial fibrillation","volume":"35","author":"Anastasio","year":"2012","journal-title":"J Interv Card Electrophysiol"},{"key":"2025110203564805100_ezw313C838","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijcard.2014.06.042","article-title":"Failure of hybrid therapy for the prevention of long-term recurrence of atrial fibrillation","volume":"176","author":"Garcia Seara","year":"2014","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C839","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0735-1097(02)02068-5","article-title":"Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy","volume":"40","author":"Saksena","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C840","article-title":"Effect of pacing modality on atrial tachyarrhythmia recurrence in the tachycardia-bradycardia syndrome: preliminary results of the Pacemaker Atrial Tachycardia Trial","volume":"98","author":"Wharton","year":"1998","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C841","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jacc.2010.05.028","article-title":"Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis","volume":"56","author":"Marinigh","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C842","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/01.STR.31.4.822","article-title":"Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation","volume":"31","author":"Gage","year":"2000","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C843","first-page":"3238","article-title":"Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis","volume":"36","author":"Andreotti","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C844","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C845","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C846","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.hrthm.2008.02.007","article-title":"Prevalence of early-onset atrial fibrillation in congenital long QT syndrome","volume":"5","author":"Johnson","year":"2008","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C847","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1046\/j.1540-8167.2003.03165.x","article-title":"Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome","volume":"14","author":"Kirchhof","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C848","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1540-8167.2008.01339.x","article-title":"Atrial Arrhythmias in long-QT syndrome under daily life conditions: a nested case control study","volume":"20","author":"Zellerhoff","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C849","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1161\/01.CIR.92.10.2929","article-title":"ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome","volume":"92","author":"Moss","year":"1995","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C850","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C851","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1046\/j.1540-8167.2001.00680.x","article-title":"Brugada syndrome and supraventricular tachyarrhythmias: a novel association?","volume":"12","author":"Eckardt","year":"2001","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C852","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.hrthm.2009.02.009","article-title":"Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome","volume":"6","author":"Kaufman","year":"2009","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C853","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.106.668392","article-title":"Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death","volume":"115","author":"Antzelevitch","year":"2007","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C854","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1161\/CIRCULATIONAHA.107.703330","article-title":"Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias","volume":"116","author":"London","year":"2007","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C855","first-page":"2260","article-title":"Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans","volume":"118","author":"Watanabe","year":"2008","journal-title":"J Clin Invest"},{"key":"2025110203564805100_ezw313C856","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.CIR.0000109482.92774.3A","article-title":"Sudden death associated with short-QT syndrome linked to mutations in HERG","volume":"109","author":"Brugada","year":"2004","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C857","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.CIR.0000085071.28695.C4","article-title":"Short QT Syndrome: a familial cause of sudden death","volume":"108","author":"Gaita","year":"2003","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C858","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/eurheartj\/ehl185","article-title":"Short QT syndrome: clinical findings and diagnostic-therapeutic implications","volume":"27","author":"Giustetto","year":"2006","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C859","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.107.711606","article-title":"Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features","volume":"116","author":"Bhuiyan","year":"2007","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C860","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.hrthm.2006.12.048","article-title":"Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia","volume":"4","author":"Napolitano","year":"2007","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C861","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1540-8167.2007.00766.x","article-title":"Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia","volume":"18","author":"Mohamed","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C862","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/clc.20057","article-title":"Clinical characteristics and outcomes of hypertrophic cardiomyopathy in Taiwan\u2014a tertiary center experience","volume":"30","author":"Lee","year":"2007","journal-title":"Clin Cardiol"},{"key":"2025110203564805100_ezw313C863","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjcard.2004.06.024","article-title":"Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy","volume":"94","author":"Losi","year":"2004","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C864","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C865","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1161\/hc5001.102111","article-title":"Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy","volume":"104","author":"Gollob","year":"2001","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C866","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/CIRCRESAHA.107.168294","article-title":"A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation","volume":"102","author":"Postma","year":"2008","journal-title":"Circ Res"},{"key":"2025110203564805100_ezw313C867","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2013.01.073","article-title":"Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians","volume":"61","author":"Marcus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C868","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.amjcard.2010.04.031","article-title":"Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia and ventricular tachycardia","volume":"106","author":"Chu","year":"2010","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C869","first-page":"1493","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with supraventricular arrhythmias\u2014executive summary. a report of the American college of cardiology\/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society","volume":"42","author":"Blomstrom-Lundqvist","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C870","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/HCO.0b013e3282f26d1b","article-title":"When should we recommend catheter ablation for patients with the Wolff-Parkinson-White syndrome?","volume":"23","author":"Tischenko","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"2025110203564805100_ezw313C871","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ancard.2007.05.006","article-title":"[Clinical and electrophysiological study of asymptomatic Wolff-Parkinson-White syndrome]","volume":"56","author":"Kibos","year":"2007","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"2025110203564805100_ezw313C872","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa035345","article-title":"A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome","volume":"349","author":"Pappone","year":"2003","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C873","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/0735-1097(90)90384-2","article-title":"Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length","volume":"16","author":"Boahene","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C874","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1111\/j.1540-8159.1991.tb02810.x","article-title":"A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome","volume":"14","author":"O'Nunain","year":"1991","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C875","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1001\/archinte.1987.00370100020005","article-title":"Supraventricular tachycardia. Mechanisms and therapy","volume":"147","author":"Manolis","year":"1987","journal-title":"Arch Intern Med"},{"key":"2025110203564805100_ezw313C876","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11739-010-0385-6","article-title":"Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation","volume":"5","author":"Simonian","year":"2010","journal-title":"Intern Emerg Med"},{"key":"2025110203564805100_ezw313C877","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","article-title":"Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review","volume":"100","author":"Guttmann","year":"2014","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C878","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C879","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/hrt.79.4.331","article-title":"Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population","volume":"79","author":"Cecchi","year":"1998","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C880","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1540-8167.2008.01192.x","article-title":"Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"19","author":"Bunch","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C881","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/euq013","article-title":"Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression","volume":"12","author":"Di Donna","year":"2010","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C882","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.amjcard.2006.12.087","article-title":"Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"99","author":"Gaita","year":"2007","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C883","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.hrthm.2005.11.013","article-title":"Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy","volume":"3","author":"Kilicaslan","year":"2006","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C884","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/europace\/euq434","article-title":"Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation","volume":"13","author":"McCready","year":"2011","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C885","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jacc.2012.04.030","article-title":"Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation","volume":"60","author":"Ritchie","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C886","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jacc.2011.11.039","article-title":"Epistatic effects of potassium channel variation on cardiac repolarization and atrial fibrillation risk","volume":"59","author":"Mann","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C887","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.hrthm.2013.10.043","article-title":"Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis","volume":"11","author":"Giustetto","year":"2014","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C888","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.107.757955","article-title":"Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation","volume":"117","author":"Darbar","year":"2008","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C889","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jama.293.4.447","article-title":"Sodium channel mutations and susceptibility to heart failure and atrial fibrillation","volume":"293","author":"Olson","year":"2005","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C890","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/hrt.2003.027227","article-title":"Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation","volume":"90","author":"Ellinor","year":"2004","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C891","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/europace\/eut272","article-title":"Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"15","author":"Priori","year":"2013","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C892","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1540-8167.2002.00231.x","article-title":"Risk of sudden death after successful accessory atrioventricular pathway ablation in resuscitated patients with Wolff-Parkinson-White syndrome","volume":"13","author":"Antz","year":"2002","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C893","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9149(99)80136-2","article-title":"Aborted sudden death in the Wolff-Parkinson-White syndrome","volume":"76","author":"Timmermans","year":"1995","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C894","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0735-1097(95)00519-6","article-title":"Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome","volume":"27","author":"Bromberg","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C895","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1016\/j.hrthm.2015.09.017","article-title":"Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: A systematic review for the 2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"13","author":"Al-Khatib","year":"2016","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C896","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","article-title":"Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine","volume":"64","author":"Maron","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C897","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0735-1097(10)80014-2","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study","volume":"15","author":"Robinson","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C898","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCULATIONAHA.108.785626","article-title":"Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study","volume":"118","author":"Mozaffarian","year":"2008","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C899","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijcard.2005.05.020","article-title":"Sport practice and the risk of lone atrial fibrillation: a case-control study","volume":"108","author":"Elosua","year":"2006","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C900","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/euhj.2001.2802","article-title":"Long-lasting sport practice and lone atrial fibrillation","volume":"23","author":"Mont","year":"2002","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C901","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/europace\/eup197","article-title":"Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis","volume":"11","author":"Abdulla","year":"2009","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C902","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1136\/heartjnl-2013-303825","article-title":"Resting heart rate and physical activity as risk factors for lone atrial fibrillation: a prospective study of 309,540 men and women","volume":"99","author":"Thelle","year":"2013","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C903","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.amjcard.2011.03.086","article-title":"Atrial remodeling, autonomic tone, and lifetime training hours in nonelite athletes","volume":"108","author":"Wilhelm","year":"2011","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C904","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jacc.2013.01.091","article-title":"Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model","volume":"62","author":"Guasch","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C905","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1093\/eurheartj\/eht188","article-title":"Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study","volume":"34","author":"Andersen","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C906","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1136\/bmj.316.7147.1784","article-title":"Lone atrial fibrillation in vigorously exercising middle aged men: case-control study","volume":"316","author":"Karjalainen","year":"1998","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C907","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.amjcard.2010.10.049","article-title":"Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities","volume":"107","author":"Biffi","year":"2011","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C908","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/europace\/eup320","article-title":"Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes","volume":"12","author":"Calvo","year":"2010","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C909","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/europace\/eur142","article-title":"Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation","volume":"13","author":"Koopman","year":"2011","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C910","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.hjr.0000239465.26132.29","article-title":"Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers","volume":"13","author":"Heidbuchel","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2025110203564805100_ezw313C911","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.amjcard.2005.11.041","article-title":"Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes","volume":"97","author":"Silversides","year":"2006","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C912","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jacep.2015.04.013","article-title":"Atrial Fibrillation or Flutter During Pregnancy in Patients With Structural Heart Disease: Data From the ROPAC (Registry on Pregnancy and Cardiac Disease)","volume":"1","author":"Salam","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C913","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","article-title":"ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)","volume":"31","author":"Baumgartner","year":"2010","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C914","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0002-8703(95)90090-X","article-title":"Treatment of arrhythmias during pregnancy","volume":"130","author":"Page","year":"1995","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C915","first-page":"CD002863","article-title":"Oral beta-blockers for mild to moderate hypertension during pregnancy","volume":"3","author":"Magee","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203564805100_ezw313C916","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00003088-198712040-00002","article-title":"The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation","volume":"12","author":"Mitani","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"2025110203564805100_ezw313C917","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-5273(02)00601-0","article-title":"Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations","volume":"88","author":"Gowda","year":"2003","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C918","article-title":"British National Formulary (online)","author":"Joint Formulary Committee"},{"key":"2025110203564805100_ezw313C919","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF03343825","article-title":"Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment","volume":"24","author":"Bartalena","year":"2001","journal-title":"J Endocrinol Invest"},{"key":"2025110203564805100_ezw313C920","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.111.026120","article-title":"Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study","volume":"124","author":"Jaeggi","year":"2011","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C921","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12471-011-0077-5","article-title":"Electrical cardioversion during pregnancy: safe or not?","volume":"19","author":"Tromp","year":"2011","journal-title":"Neth Heart J"},{"key":"2025110203564805100_ezw313C922","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1701-2163(16)34767-3","article-title":"The acute treatment of maternal supraventricular tachycardias during pregnancy: a review of the literature","volume":"33","author":"Ghosh","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"2025110203564805100_ezw313C923","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"2025110203564805100_ezw313C924","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.athoracsur.2006.11.047","article-title":"Postoperative atrial fibrillation is not correlated to C-reactive protein","volume":"83","author":"Ahlsson","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C925","first-page":"Cd003611","article-title":"Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery","volume":"1","author":"Arsenault","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203564805100_ezw313C926","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/jama.291.14.1720","article-title":"A multicenter risk index for atrial fibrillation after cardiac surgery","volume":"291","author":"Mathew","year":"2004","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C927","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/clc.22230","article-title":"Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry","volume":"37","author":"Steinberg","year":"2014","journal-title":"Clin Cardiol"},{"key":"2025110203564805100_ezw313C928","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/anec.12004","article-title":"Prevention of post-coronary artery bypass grafting (CABG) atrial fibrillation: efficacy of prophylactic beta-blockers in the modern era: a meta-analysis of latest randomized controlled trials","volume":"18","author":"Khan","year":"2013","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2025110203564805100_ezw313C929","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/eurheartj\/ehl272","article-title":"Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis","volume":"27","author":"Burgess","year":"2006","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C930","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/pace.12140","article-title":"Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis","volume":"36","author":"Chatterjee","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C931","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1445-5994.2012.02844.x","article-title":"Meta-analysis of amiodarone versus beta-blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery","volume":"42","author":"Zhu","year":"2012","journal-title":"Intern Med J"},{"key":"2025110203564805100_ezw313C932","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/HCO.0b013e32835b0956","article-title":"Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials","volume":"28","author":"Fauchier","year":"2013","journal-title":"Curr Opin Cardiol"},{"key":"2025110203564805100_ezw313C933","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/FJC.0000000000000102","article-title":"The use of statins to prevent postoperative atrial fibrillation after coronary artery bypass grafting: a meta-analysis of 12 studies","volume":"64","author":"Zheng","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"2025110203564805100_ezw313C934","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMoa1507750","article-title":"Perioperative Rosuvastatin in Cardiac Surgery","volume":"374","author":"Zheng","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C935","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.athoracsur.2012.09.008","article-title":"Prophylactic magnesium does not prevent atrial fibrillation after cardiac surgery: a meta-analysis","volume":"95","author":"Cook","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C936","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1053\/j.jvca.2012.03.012","article-title":"Systemic magnesium to reduce postoperative arrhythmias after coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials","volume":"26","author":"De Oliveira","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203564805100_ezw313C937","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jtcvs.2013.03.015","article-title":"Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis","volume":"146","author":"Costanzo","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C938","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.amjcard.2011.04.036","article-title":"Effect of dietary fish oil on atrial fibrillation after cardiac surgery","volume":"108","author":"Farquharson","year":"2011","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C939","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/europace\/eup429","article-title":"Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?","volume":"12","author":"Heidarsdottir","year":"2010","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C940","doi-asserted-by":"crossref","first-page":"e005033","DOI":"10.1161\/JAHA.112.005033","article-title":"N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials","volume":"2","author":"Mariani","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2025110203564805100_ezw313C941","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.jacc.2013.07.014","article-title":"A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement","volume":"62","author":"Rodrigo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C942","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/CIRCEP.109.899633","article-title":"Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial","volume":"3","author":"Saravanan","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C943","doi-asserted-by":"crossref","first-page":"e000397","DOI":"10.1161\/JAHA.113.000397","article-title":"Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial","volume":"2","author":"Wu","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2025110203564805100_ezw313C944","doi-asserted-by":"crossref","first-page":"e72913","DOI":"10.1371\/journal.pone.0072913","article-title":"Fish oil and atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials","volume":"8","author":"Xin","year":"2013","journal-title":"PLoS One"},{"key":"2025110203564805100_ezw313C945","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jjcc.2013.06.014","article-title":"Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: an updated meta-analysis of randomized controlled trials","volume":"63","author":"Zhang","year":"2014","journal-title":"J Cardiol"},{"key":"2025110203564805100_ezw313C946","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.2014.11026","article-title":"Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial","volume":"312","author":"Imazio","year":"2014","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C947","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.jvca.2010.03.015","article-title":"Protective effects of steroids in cardiac surgery: a meta-analysis of randomized double-blind trials","volume":"25","author":"Cappabianca","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203564805100_ezw313C948","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/icvts\/ivt486","article-title":"Is perioperative corticosteroid administration associated with a reduced incidence of postoperative atrial fibrillation in adult cardiac surgery?","volume":"18","author":"Viviano","year":"2014","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203564805100_ezw313C949","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/icvts\/ivr099","article-title":"Does posterior pericardiotomy reduce the incidence of atrial fibrillation after coronary artery bypass grafting surgery?","volume":"14","author":"Kaleda","year":"2012","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203564805100_ezw313C950","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ejcts.2006.09.003","article-title":"Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery","volume":"30","author":"Dunning","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C951","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.athoracsur.2014.03.039","article-title":"Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs","volume":"98","author":"LaPar","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2025110203564805100_ezw313C952","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjcard.2011.08.033","article-title":"Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients)","volume":"109","author":"Saxena","year":"2012","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C953","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jama.2014.9143","article-title":"Perioperative atrial fibrillation and the long-term risk of ischemic stroke","volume":"312","author":"Gialdini","year":"2014","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C954","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/14017430802702291","article-title":"Patients with postoperative atrial fibrillation have a doubled cardiovascular mortality","volume":"43","author":"Ahlsson","year":"2009","journal-title":"Scand Cardiovasc J"},{"key":"2025110203564805100_ezw313C955","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.ejcts.2009.12.033","article-title":"Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality","volume":"37","author":"Ahlsson","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C956","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.108.777789","article-title":"Atrial fibrillation after isolated coronary surgery affects late survival","volume":"118","author":"Mariscalco","year":"2008","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C957","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2003.11.023","article-title":"Postoperative atrial fibrillation and mortality after coronary artery bypass surgery","volume":"43","author":"Villareal","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C958","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ejcts\/ezu551","article-title":"New-onset atrial fibrillation following coronary bypass surgery predicts long-term mortality: a systematic review and meta-analysis","volume":"48","author":"Phan","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203564805100_ezw313C959","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jacc.2009.10.058","article-title":"New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft","volume":"55","author":"El-Chami","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C960","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cll.2014.06.012","article-title":"Anticoagulation strategies for the management of postoperative atrial fibrillation","volume":"34","author":"Anderson","year":"2014","journal-title":"Clin Lab Med"},{"key":"2025110203564805100_ezw313C961","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/14017431.2012.740572","article-title":"Pharmacological conversion of recent-onset atrial fibrillation: a systematic review","volume":"47","author":"Heldal","year":"2013","journal-title":"Scand Cardiovasc J Suppl"},{"key":"2025110203564805100_ezw313C962","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","article-title":"Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery","volume":"374","author":"Gillinov","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203564805100_ezw313C963","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/heart.87.4.383","article-title":"Arrhythmias in adults with congenital heart disease","volume":"87","author":"Triedman","year":"2002","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C964","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijcard.2010.09.028","article-title":"Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease","volume":"154","author":"Ammash","year":"2012","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C965","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1092-9126(03)70009-X","article-title":"Surgical management of atrial tachyarrhythmias associated with congenital cardiac anomalies: Mayo Clinic experience","volume":"6","author":"Greason","year":"2003","journal-title":"Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu"},{"key":"2025110203564805100_ezw313C966","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ccell.2011.04.001","article-title":"Acute cardiac arrhythmias following surgery for congenital heart disease: mechanisms, diagnostic tools, and management","volume":"23","author":"Payne","year":"2011","journal-title":"Crit Care Nurs Clin North Am"},{"key":"2025110203564805100_ezw313C967","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/CIRCULATIONAHA.112.104786","article-title":"Sudden cardiac death in adult congenital heart disease","volume":"126","author":"Koyak","year":"2012","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C968","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/heartjnl-2014-305576","article-title":"Anticoagulation in adults with congenital heart disease: The who, the when and the how?","volume":"101","author":"Jensen","year":"2014","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C969","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jjcc.2009.01.009","article-title":"Management of late atrial tachyarrhythmia long after Fontan operation","volume":"53","author":"Fujita","year":"2009","journal-title":"J Cardiol"},{"key":"2025110203564805100_ezw313C970","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/0735-1097(94)90121-X","article-title":"Transesophageal echocardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease","volume":"24","author":"Feltes","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C971","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3143\/geriatrics.32.27","article-title":"[Studies on atrial arrhythmias in atrial septal defect. The influences of aging on atrial fibrillation]","volume":"32","author":"Nagao","year":"1995","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"2025110203564805100_ezw313C972","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2007.06.019","article-title":"Surgical treatment of arrhythmias in adults with congenital heart defects","volume":"129","author":"Giamberti","year":"2008","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C973","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0195-668X(02)00383-4","article-title":"Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years","volume":"24","author":"Roos-Hesselink","year":"2003","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C974","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1253\/circj.71.1989","article-title":"Pulmonary vein isolation in patients with paroxysmal atrial fibrillation after direct suture closure of congenital atrial septal defect","volume":"71","author":"Yamada","year":"2007","journal-title":"Circ J"},{"key":"2025110203564805100_ezw313C975","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2010.07.014","article-title":"The importance of pulmonary artery pressures on late atrial arrhythmia in transcatheter and surgically closed ASD type secundum","volume":"152","author":"Van De Bruaene","year":"2011","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C976","first-page":"239","article-title":"[Rhythm disorders occurring after surgical closure of the interatrial communication]","volume":"30","author":"de Salle","year":"1975","journal-title":"Acta Cardiol"},{"key":"2025110203564805100_ezw313C977","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/europace\/euu076","article-title":"Very long-term results of electroanatomic-guided radiofrequency ablation of atrial arrhythmias in patients with surgically corrected atrial septal defect","volume":"16","author":"Scaglione","year":"2014","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C978","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1540-8159.1997.tb06207.x","article-title":"Atrial arrhythmias during chronic follow-up of surgery for complex congenital heart disease","volume":"20","author":"Kanter","year":"1997","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C979","first-page":"318","article-title":"Incidence and management of dysrhythmias after Fontan procedure","volume":"18","author":"Porter","year":"1993","journal-title":"Herz"},{"key":"2025110203564805100_ezw313C980","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/0735-1097(94)90181-3","article-title":"Risk factors for atrial tachyarrhythmias after the Fontan operation","volume":"24","author":"Gelatt","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"2025110203564805100_ezw313C981","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/hrt.68.8.199","article-title":"Arrhythmias after the Fontan procedure","volume":"68","author":"Peters","year":"1992","journal-title":"Br Heart J"},{"key":"2025110203564805100_ezw313C982","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1540-8191.2009.00914.x","article-title":"Surgical therapy of arrhythmias in single-ventricle patients undergoing Fontan or Fontan conversion","volume":"24","author":"Kwak","year":"2009","journal-title":"J Card Surg"},{"key":"2025110203564805100_ezw313C983","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.pcsu.2008.03.001","article-title":"Maze procedure in single ventricle patients","volume":"11","author":"Backer","year":"2008","journal-title":"Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu"},{"key":"2025110203564805100_ezw313C984","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1111\/j.1540-8159.2008.00947.x","article-title":"The role of concomitant arrhythmia surgery in patients undergoing repair of congenital heart disease","volume":"31","author":"Deal","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203564805100_ezw313C985","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10840-007-9181-2","article-title":"Atrial arrhythmia surgery in congenital heart disease","volume":"20","author":"Gandhi","year":"2007","journal-title":"J Interv Card Electrophysiol"},{"key":"2025110203564805100_ezw313C986","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1161\/CIRCEP.114.001758","article-title":"Mechanism and ablation of arrhythmia following total cavopulmonary connection","volume":"8","author":"Correa","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C987","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCULATIONAHA.109.928481","article-title":"Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study","volume":"122","author":"Khairy","year":"2010","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C988","first-page":"II399","article-title":"Maze procedure for atrial fibrillation associated with atrial septal defect","volume":"98","author":"Kobayashi","year":"1998","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C989","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5090\/kjtcs.2013.46.2.98","article-title":"Efficacy of the maze procedure for atrial fibrillation associated with atrial septal defect","volume":"46","author":"Shim","year":"2013","journal-title":"Korean J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C990","first-page":"434","article-title":"Atrial tachyarrhythmias and the Cox-maze procedure in congenital heart disease","volume":"8","author":"Gutierrez","year":"2013","journal-title":"Congenit Heart Dis"},{"key":"2025110203564805100_ezw313C991","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/CIRCEP.113.000313","article-title":"Update on interventional electrophysiology in congenital heart disease: evolving solutions for complex hearts","volume":"6","author":"Sherwin","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203564805100_ezw313C992","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.CIR.0000027683.00417.9A","article-title":"Contemporary management of atrial flutter","volume":"106","author":"Wellens","year":"2002","journal-title":"Circulation"},{"key":"2025110203564805100_ezw313C993","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/heart.90.1.59","article-title":"Long term follow up of radiofrequency catheter ablation of atrial flutter: clinical course and predictors of atrial fibrillation occurrence","volume":"90","author":"Bertaglia","year":"2004","journal-title":"Heart"},{"key":"2025110203564805100_ezw313C994","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00392-014-0682-6","article-title":"Risk of atrial fibrillation, stroke, and death after radiofrequency catheter ablation of typical atrial flutter","volume":"103","author":"Seara","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"2025110203564805100_ezw313C995","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/jce.12413","article-title":"Risk of atrial fibrillation after atrial flutter ablation: impact of AF history, gender, and antiarrhythmic drug medication","volume":"25","author":"Brembilla-Perrot","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C996","first-page":"171","article-title":"Vernakalant: review of a novel atrial selective antiarrhythmic agent and its place in current treatment of atrial fibrillation","volume":"7","author":"Bronis","year":"2012","journal-title":"Hosp Chronicles"},{"key":"2025110203564805100_ezw313C997","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3122\/jabfm.2011.01.080096","article-title":"Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation","volume":"24","author":"Nair","year":"2011","journal-title":"J Am Board Fam Med"},{"key":"2025110203564805100_ezw313C998","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ajem.2008.10.028","article-title":"Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks","volume":"28","author":"Reisinger","year":"2010","journal-title":"Am J Emerg Med"},{"key":"2025110203564805100_ezw313C999","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-8703(99)70489-8","article-title":"A comparison of 50-J versus 100-J shocks for direct-current cardioversion of atrial flutter","volume":"137","author":"Pinski","year":"1999","journal-title":"Am Heart J"},{"key":"2025110203564805100_ezw313C1000","first-page":"143","article-title":"Transesophageal overdrive pacing: A simple and versatile tool","volume":"8","author":"Manolis","year":"2013","journal-title":"Hosp Chronicles"},{"key":"2025110203564805100_ezw313C1001","first-page":"20","article-title":"Transvenous temporary cardiac pacing","volume":"9","author":"Poulidakis","year":"2014","journal-title":"Rhythmos"},{"key":"2025110203564805100_ezw313C1002","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.amjcard.2009.04.040","article-title":"Meta-analysis of ablation of atrial flutter and supraventricular tachycardia","volume":"104","author":"Spector","year":"2009","journal-title":"Am J Cardiol"},{"key":"2025110203564805100_ezw313C1003","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0195-668X(02)00846-1","article-title":"Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the occurrence of atrial fibrillation","volume":"24","author":"Schmieder","year":"2003","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C1004","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2459\/JCM.0b013e3283403301","article-title":"Atrial fibrillation after typical atrial flutter ablation: a long-term follow-up","volume":"12","author":"Bandini","year":"2011","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2025110203564805100_ezw313C1005","doi-asserted-by":"crossref","first-page":"e100509","DOI":"10.1371\/journal.pone.0100509","article-title":"Healthcare utilization and clinical outcomes after catheter ablation of atrial flutter","volume":"9","author":"Dewland","year":"2014","journal-title":"PLoS One"},{"key":"2025110203564805100_ezw313C1006","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.hrthm.2008.12.013","article-title":"Color-coded three-dimensional entrainment mapping for analysis and treatment of atrial macroreentrant tachycardia","volume":"6","author":"Esato","year":"2009","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C1007","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/jce.12406","article-title":"Atrial Arrhythmias Following Surgical AF Ablation: Electrophysiological Findings, Ablation Strategies, and Clinical Outcome","volume":"25","author":"Huo","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203564805100_ezw313C1008","article-title":"Crossing the Quality Chasm: A New Health System for the 21st Century","author":"Institute of Medicine Committee on Quality of Health Care in America","year":"2001"},{"key":"2025110203564805100_ezw313C1009","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.288.14.1775","article-title":"Improving primary care for patients with chronic illness","volume":"288","author":"Bodenheimer","year":"2002","journal-title":"JAMA"},{"key":"2025110203564805100_ezw313C1010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1377\/hlthaff.2012.1061","article-title":"What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs","volume":"32","author":"Hibbard","year":"2013","journal-title":"Health Aff (Millwood)"},{"key":"2025110203564805100_ezw313C1011","first-page":"37","article-title":"Self-management of atrial fibrillation: a new frontier for nursing research","volume":"23","author":"McCabe","year":"2008","journal-title":"Prog Cardiovasc Nurs"},{"key":"2025110203564805100_ezw313C1012","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/hs0102.101817","article-title":"Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project","volume":"33","author":"Lip","year":"2002","journal-title":"Stroke"},{"key":"2025110203564805100_ezw313C1013","first-page":"Cd008600","article-title":"Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation","volume":"6","author":"Clarkesmith","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203564805100_ezw313C1014","doi-asserted-by":"crossref","first-page":"e74037","DOI":"10.1371\/journal.pone.0074037","article-title":"Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial","volume":"8","author":"Clarkesmith","year":"2013","journal-title":"PLoS One"},{"key":"2025110203564805100_ezw313C1015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2261-10-21","article-title":"TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)","volume":"10","author":"Smith","year":"2010","journal-title":"BMC Cardiovasc Disord"},{"key":"2025110203564805100_ezw313C1016","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000314936","article-title":"Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategies","volume":"116","author":"Smith","year":"2010","journal-title":"Cardiology"},{"key":"2025110203564805100_ezw313C1017","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/europace\/euq109","article-title":"An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality","volume":"12","author":"Aliot","year":"2010","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C1018","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.ijcard.2012.12.047","article-title":"The atrial fibrillation knowledge scale: development, validation and results","volume":"168","author":"Hendriks","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025110203564805100_ezw313C1019","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/JMDH.S19315","article-title":"What patients want and need to know about atrial fibrillation","volume":"4","author":"McCabe","year":"2011","journal-title":"J Multidiscip Healthc"},{"key":"2025110203564805100_ezw313C1020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1207\/S15324796ABM2601_01","article-title":"Self-management education: history, definition, outcomes, and mechanisms","volume":"26","author":"Lorig","year":"2003","journal-title":"Ann Behav Med"},{"key":"2025110203564805100_ezw313C1021","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1136\/bmj.e256","article-title":"Shared decision making: really putting patients at the centre of healthcare","volume":"344","author":"Stiggelbout","year":"2012","journal-title":"BMJ"},{"key":"2025110203564805100_ezw313C1022","first-page":"CD001431","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"1","author":"Stacey","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203564805100_ezw313C1023","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice","volume":"27","author":"Elwyn","year":"2012","journal-title":"J Gen Intern Med"},{"key":"2025110203564805100_ezw313C1024","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.hrthm.2014.11.011","article-title":"Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013","volume":"12","author":"Van Wagoner","year":"2015","journal-title":"Heart Rhythm"},{"key":"2025110203564805100_ezw313C1025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s13063-015-0898-4","article-title":"Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial","volume":"16","author":"van Nieuwenhuizen","year":"2015","journal-title":"Trials"},{"key":"2025110203564805100_ezw313C1026","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/europace\/eut106","article-title":"Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study","volume":"15","author":"Gronberg","year":"2013","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C1027","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1023\/B:CEPR.0000023139.45437.93","article-title":"Does sinus rhythm beget sinus rhythm? Effects of prompt cardioversion on the frequency and persistence of recurrent atrial fibrillation","volume":"7","author":"Tse","year":"2003","journal-title":"Card Electrophysiol Rev"},{"key":"2025110203564805100_ezw313C1028","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/europace\/eul107","article-title":"The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm","volume":"8","author":"Van Gelder","year":"2006","journal-title":"Europace"},{"key":"2025110203564805100_ezw313C1029","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.avsg.2011.09.009","article-title":"Updated systematic review and meta-analysis of randomized clinical trials comparing carotid artery stenting and carotid endarterectomy in the treatment of carotid stenosis","volume":"26","author":"Liu","year":"2012","journal-title":"Ann Vasc Surg"},{"key":"2025110203564805100_ezw313C1030","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0140-6736(99)05388-X","article-title":"Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial","volume":"353","author":"Taylor","year":"1999","journal-title":"Lancet"},{"key":"2025110203564805100_ezw313C1031","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jvs.2014.11.001","article-title":"The effect of atrial fibrillation on outcomes in patients undergoing carotid endarterectomy or stent placement in general practice","volume":"61","author":"Watanabe","year":"2015","journal-title":"J Vasc Surg"},{"key":"2025110203564805100_ezw313C1032","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1093\/eurheartj\/ehu305","article-title":"Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial","volume":"35","author":"Breithardt","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C1033","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/eurheartj\/ehv163","article-title":"Prognostic value of CHA2DS2-VASc score in patients with \u2018non-valvular atrial fibrillation\u2019 and valvular heart disease: the Loire Valley Atrial Fibrillation Project","volume":"36","author":"Philippart","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C1034","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/eurheartj\/ehv193","article-title":"Valvular heart disease among non-valvular atrial fibrillation: a misnomer, in search of a new term","volume":"36","author":"Breithardt","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203564805100_ezw313C1035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jtcvs.2005.03.041","article-title":"Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation","volume":"130","author":"Wolf","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C1036","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jtcvs.2008.01.035","article-title":"Completely thoracoscopic bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation","volume":"136","author":"Yilmaz","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C1037","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jtcvs.2009.06.033","article-title":"Left atrial appendage clip occlusion: early clinical results","volume":"139","author":"Salzberg","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203564805100_ezw313C1038","author":"Papworth Hospital NHS Foundation Trust"},{"key":"2025110203564805100_ezw313C1039"},{"key":"2025110203564805100_ezw313C1040"},{"key":"2025110203564805100_ezw313C1041"},{"key":"2025110203564805100_ezw313C1042","article-title":"Catheter ablation in patients with persistent atrial fibrillation","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/50\/5\/e1\/64102825\/ejcts_50_5_e1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/50\/5\/e1\/64102825\/ejcts_50_5_e1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:58:39Z","timestamp":1762073919000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/50\/5\/e1\/2444542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,23]]},"references-count":1042,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezw313","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,11]]},"published":{"date-parts":[[2016,9,23]]}}}